| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | NID2 STAB2 DLL4 ENPP2 FAT3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 1.20e-14 | 749 | 97 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 TINAGL1 FBN1 FBN2 HMCN1 MEGF9 LTBP1 LTBP2 TNXB FBN3 | 1.82e-14 | 188 | 97 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 TINAGL1 KLHL3 FBN1 FBN2 HMCN1 MEGF9 JAG1 LTBP1 LTBP2 RIMS2 TNXB FBN3 | 2.50e-07 | 891 | 97 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.11e-07 | 16 | 97 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.94e-06 | 21 | 97 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.61e-06 | 85 | 97 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.63e-05 | 120 | 97 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.14e-04 | 156 | 97 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.39e-04 | 4 | 97 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | hyaluronan synthase activity | 1.39e-04 | 4 | 97 | 2 | GO:0050501 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.35e-04 | 62 | 97 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.99e-04 | 27 | 97 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | microfibril binding | 3.46e-04 | 6 | 97 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.34e-04 | 200 | 97 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 4.41e-04 | 73 | 97 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | insulin-like growth factor II binding | 6.42e-04 | 8 | 97 | 2 | GO:0031995 | |
| GeneOntologyMolecularFunction | syndecan binding | 8.22e-04 | 9 | 97 | 2 | GO:0045545 | |
| GeneOntologyMolecularFunction | fibronectin binding | 8.29e-04 | 38 | 97 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | molecular function activator activity | SPRY2 ERBB3 DLL4 INHBB SEMA5A FBN1 FBN2 IGFBP3 EGF DKK1 CSPG5 BRPF1 JAG1 ARHGAP29 GPRC5D | 8.64e-04 | 1233 | 97 | 15 | GO:0140677 |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.18e-03 | 430 | 97 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.25e-03 | 11 | 97 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | peptidase activity | CYLD CLCA4 TMEM59 ADAM30 ADAM11 TINAGL1 PRSS47P ADAMTS7 TLL1 TLL2 | 1.29e-03 | 654 | 97 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | receptor ligand activity | 1.37e-03 | 547 | 97 | 9 | GO:0048018 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.49e-03 | 12 | 97 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 1.49e-03 | 12 | 97 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.50e-03 | 554 | 97 | 9 | GO:0030546 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.56e-03 | 173 | 97 | 5 | GO:0008083 | |
| GeneOntologyMolecularFunction | integrin binding | 1.64e-03 | 175 | 97 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.76e-03 | 13 | 97 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.95e-03 | 51 | 97 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.97e-03 | 268 | 97 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.05e-03 | 14 | 97 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.05e-03 | 14 | 97 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.03e-03 | 17 | 97 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 3.06e-03 | 616 | 97 | 9 | GO:0030545 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 3.40e-03 | 18 | 97 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.43e-03 | 127 | 97 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 3.78e-03 | 19 | 97 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | zinc ion binding | CYLD PRICKLE1 ENPP2 ADAM30 TUT1 UPF1 SEC24D TLL1 TLL2 SUV39H1 PRICKLE2 | 3.95e-03 | 891 | 97 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.19e-03 | 20 | 97 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.93e-03 | 323 | 97 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.20e-03 | 72 | 97 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 6.03e-03 | 149 | 97 | 4 | GO:0030295 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 6.97e-03 | 80 | 97 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 7.04e-03 | 26 | 97 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | collagen binding | 7.21e-03 | 81 | 97 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | helicase activity | 7.40e-03 | 158 | 97 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | kinase activator activity | 7.56e-03 | 159 | 97 | 4 | GO:0019209 | |
| GeneOntologyMolecularFunction | Notch binding | 7.57e-03 | 27 | 97 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | DGCR2 SPRY2 PRICKLE1 DLL4 TNC FAT3 MUC19 LAMA3 LAMB3 CRB1 KLHL3 FAT1 CELSR1 FBN2 DKK1 IGFBP5 MEGF9 JAG1 LRP6 LRP5 LTBP3 HAS2 | 6.31e-08 | 1269 | 96 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | NID2 PRICKLE1 LAMB3 SEMA5A HMCN1 ADAMTS7 TLL1 TLL2 LRP1 HAS2 HAS3 TNXB | 1.84e-07 | 377 | 96 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | NID2 PRICKLE1 LAMB3 SEMA5A HMCN1 ADAMTS7 TLL1 TLL2 LRP1 HAS2 HAS3 TNXB | 1.89e-07 | 378 | 96 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | NID2 PRICKLE1 LAMB3 SEMA5A HMCN1 ADAMTS7 TLL1 TLL2 LRP1 HAS2 HAS3 TNXB | 1.94e-07 | 379 | 96 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 3.05e-07 | 13 | 96 | 4 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 3.05e-07 | 13 | 96 | 4 | GO:1900116 | |
| GeneOntologyBiologicalProcess | ossification | PRICKLE1 TNC NELL1 FBN2 IGFBP3 DKK1 IGFBP5 ADAMTS7 JAG1 SUV39H1 SCUBE3 LRP6 LRP5 LTBP3 | 3.25e-07 | 562 | 96 | 14 | GO:0001503 |
| GeneOntologyBiologicalProcess | tube development | SPRY2 STAB2 PRICKLE1 DLL4 INHBB TNC MUC19 SEMA5A ITGB2 KLHL3 CELSR1 FBN1 EGF IGFBP5 BRPF1 JAG1 LRP1 LRP6 LRP5 LTBP3 HAS2 NOTCH3 | 3.55e-07 | 1402 | 96 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.90e-07 | 4 | 96 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SPRY2 PRICKLE1 DLL4 TNC SEMA5A KLHL3 FAT1 CELSR1 EGF IGFBP5 BRPF1 JAG1 LRP6 LRP5 | 1.03e-06 | 619 | 96 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SPRY2 PRICKLE1 DLL4 TNC SEMA5A KLHL3 FAT1 CELSR1 EGF DKK1 IGFBP5 BRPF1 JAG1 LRP6 LRP5 | 1.89e-06 | 750 | 96 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 4.03e-06 | 198 | 96 | 8 | GO:0048754 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | SPRY2 PRICKLE1 DLL4 TNC SEMA5A KLHL3 CELSR1 EGF BRPF1 LRP6 LRP5 | 4.18e-06 | 421 | 96 | 11 | GO:0060562 |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 5.38e-06 | 8 | 96 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 5.69e-06 | 55 | 96 | 5 | GO:0060071 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | SPRY2 INHBB FBN1 FBN2 DKK1 TGFBRAP1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 | 7.07e-06 | 445 | 96 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 8.07e-06 | 59 | 96 | 5 | GO:0085029 | |
| GeneOntologyBiologicalProcess | respiratory system development | 1.26e-05 | 305 | 96 | 9 | GO:0060541 | |
| GeneOntologyBiologicalProcess | response to growth factor | SPRY2 DLL4 TNC FBN1 FBN2 DKK1 ADAMTS7 TGFBRAP1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 HAS2 TNXB | 1.35e-05 | 883 | 96 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.46e-05 | 236 | 96 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | SPRY2 INHBB FBN1 FBN2 DKK1 TGFBRAP1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 | 1.49e-05 | 482 | 96 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | tube morphogenesis | SPRY2 STAB2 PRICKLE1 DLL4 TNC SEMA5A ITGB2 KLHL3 CELSR1 EGF BRPF1 JAG1 LRP1 LRP6 LRP5 HAS2 NOTCH3 | 1.55e-05 | 1125 | 96 | 17 | GO:0035239 |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.57e-05 | 11 | 96 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.13e-05 | 410 | 96 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | establishment of bipolar cell polarity involved in cell morphogenesis | 2.14e-05 | 2 | 96 | 2 | GO:0061159 | |
| GeneOntologyBiologicalProcess | blood vessel development | SPRY2 STAB2 PRICKLE1 DLL4 LAMA4 SEMA5A ITGB2 EGF BRPF1 JAG1 LRP1 LRP5 LTBP1 HAS2 NOTCH3 | 2.45e-05 | 929 | 96 | 15 | GO:0001568 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 2.76e-05 | 258 | 96 | 8 | GO:0001763 | |
| GeneOntologyBiologicalProcess | axis elongation | 2.88e-05 | 38 | 96 | 4 | GO:0003401 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 2.98e-05 | 77 | 96 | 5 | GO:0035567 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | SPRY2 ERBB3 PRICKLE1 INHBB FBN1 FBN2 IGFBP3 EGF DKK1 IGFBP5 TGFBRAP1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB | 3.05e-05 | 1186 | 96 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | tissue remodeling | 3.08e-05 | 262 | 96 | 8 | GO:0048771 | |
| GeneOntologyBiologicalProcess | circulatory system development | SPRY2 ERBB3 STAB2 PRICKLE1 DLL4 LAMA4 SEMA5A ITGB2 FBN1 EGF DKK1 BRPF1 JAG1 LRP1 LRP6 LRP5 LTBP1 HAS2 NOTCH3 | 3.11e-05 | 1442 | 96 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | hyaluronan metabolic process | 3.54e-05 | 40 | 96 | 4 | GO:0030212 | |
| GeneOntologyBiologicalProcess | aorta development | 3.59e-05 | 80 | 96 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | artery development | 3.70e-05 | 133 | 96 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SPRY2 DLL4 FBN1 FBN2 DKK1 ADAMTS7 TGFBRAP1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 HAS2 TNXB | 3.79e-05 | 850 | 96 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | vasculature development | SPRY2 STAB2 PRICKLE1 DLL4 LAMA4 SEMA5A ITGB2 EGF BRPF1 JAG1 LRP1 LRP5 LTBP1 HAS2 NOTCH3 | 3.98e-05 | 969 | 96 | 15 | GO:0001944 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 4.45e-05 | 276 | 96 | 8 | GO:0007179 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 4.73e-05 | 43 | 96 | 4 | GO:0071711 | |
| GeneOntologyBiologicalProcess | hyaluronan biosynthetic process | 5.24e-05 | 16 | 96 | 3 | GO:0030213 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast differentiation | 5.68e-05 | 88 | 96 | 5 | GO:0045669 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 5.97e-05 | 372 | 96 | 9 | GO:0060485 | |
| GeneOntologyBiologicalProcess | establishment of bipolar cell polarity | 6.41e-05 | 3 | 96 | 2 | GO:0061171 | |
| GeneOntologyBiologicalProcess | regulation of ovulation | 6.41e-05 | 3 | 96 | 2 | GO:0060278 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 6.47e-05 | 147 | 96 | 6 | GO:0030278 | |
| GeneOntologyBiologicalProcess | eye development | 8.00e-05 | 480 | 96 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | neuron projection development | PRICKLE1 TNC FAT3 LAMA3 LAMB3 SPIRE1 SEMA5A DKK1 MICALL2 MEGF9 CSPG5 PRICKLE2 LRP1 LRP6 RIMS2 TNXB NOTCH3 | 8.27e-05 | 1285 | 96 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 8.37e-05 | 302 | 96 | 8 | GO:0001649 | |
| GeneOntologyBiologicalProcess | visual system development | 8.43e-05 | 483 | 96 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 9.65e-05 | 491 | 96 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PRICKLE1 ENPP2 FAT3 LAMA3 LAMB3 SEMA5A ITGB2 CRB1 FAT1 DKK1 MEGF9 CSPG5 LRP1 LRP6 RIMS2 NOTCH3 | 1.19e-04 | 1194 | 96 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | PRICKLE1 TNC FAT3 LAMA3 LAMB3 SPIRE1 SEMA5A CRB1 DKK1 MICALL2 MEGF9 CSPG5 PRICKLE2 LRP1 LRP6 RIMS2 TNXB NOTCH3 | 1.25e-04 | 1463 | 96 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway involved in somitogenesis | 1.28e-04 | 4 | 96 | 2 | GO:0090244 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | SPRY2 DLL4 TNC ENPP2 LAMA3 LAMA4 SEMA5A FAT1 FBN2 IGFBP3 EGF IGFBP5 JAG1 LRP1 HAS2 TNXB | 1.40e-04 | 1211 | 96 | 16 | GO:0030334 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | CYLD PRICKLE1 SEMA5A CELSR1 EGF DKK1 PRICKLE2 LRP1 LRP6 LRP5 | 1.45e-04 | 516 | 96 | 10 | GO:0016055 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.49e-04 | 171 | 96 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.57e-04 | 109 | 96 | 5 | GO:0034446 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.67e-04 | 426 | 96 | 9 | GO:0043010 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.74e-04 | 336 | 96 | 8 | GO:0071560 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.82e-04 | 338 | 96 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.01e-04 | 343 | 96 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.01e-04 | 343 | 96 | 8 | GO:0071559 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 2.09e-04 | 25 | 96 | 3 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 2.09e-04 | 25 | 96 | 3 | GO:0050962 | |
| GeneOntologyBiologicalProcess | Norrin signaling pathway | 2.12e-04 | 5 | 96 | 2 | GO:0110135 | |
| GeneOntologyBiologicalProcess | positive regulation of hyaluronan biosynthetic process | 2.12e-04 | 5 | 96 | 2 | GO:1900127 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | SPRY2 DLL4 TNC ENPP2 LAMA3 LAMA4 SEMA5A FAT1 FBN2 IGFBP3 EGF IGFBP5 JAG1 LRP1 HAS2 TNXB | 2.63e-04 | 1280 | 96 | 16 | GO:2000145 |
| GeneOntologyBiologicalProcess | lung development | 2.63e-04 | 269 | 96 | 7 | GO:0030324 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 2.79e-04 | 192 | 96 | 6 | GO:0045667 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.88e-04 | 273 | 96 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | embryo development | SPRY2 PRICKLE1 DLL4 LAMA3 LAMA4 LRP1B SEC24D CELSR1 KMT2D FBN2 DKK1 BRPF1 JAG1 SUV39H1 PRICKLE2 LRP6 LRP5 | 3.15e-04 | 1437 | 96 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | establishment of blood-retinal barrier | 3.18e-04 | 6 | 96 | 2 | GO:1990963 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | CYLD ERBB3 TNC ENPP2 LAMA3 LAMA4 SEMA5A ITGB2 CSPG5 JAG1 LRP1 HAS2 TNXB | 3.58e-04 | 927 | 96 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | ERBB3 DLL4 TNC ENPP2 SEMA5A KMT2D EGF IGFBP5 LRP6 LRP5 LTBP3 HAS2 TNXB CDCA7L NOTCH3 | 3.82e-04 | 1190 | 96 | 15 | GO:0008284 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 3.85e-04 | 204 | 96 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | regionalization | 3.90e-04 | 478 | 96 | 9 | GO:0003002 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | SPRY2 DLL4 TNC ENPP2 LAMA3 LAMA4 SEMA5A FAT1 FBN2 IGFBP3 EGF IGFBP5 JAG1 LRP1 HAS2 TNXB | 3.92e-04 | 1327 | 96 | 16 | GO:0040012 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | SPRY2 STAB2 DLL4 SEMA5A ITGB2 EGF BRPF1 JAG1 LRP1 LRP5 HAS2 NOTCH3 | 4.06e-04 | 817 | 96 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | epithelium development | SPRY2 PRICKLE1 DLL4 TNC SEMA5A KLHL3 FAT1 CELSR1 EGF DKK1 IGFBP5 BRPF1 JAG1 LRP6 LRP5 GPRC5D HYDIN | 4.07e-04 | 1469 | 96 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 4.09e-04 | 134 | 96 | 5 | GO:0014910 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 4.23e-04 | 291 | 96 | 7 | GO:0045444 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 4.37e-04 | 76 | 96 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYLD PRICKLE1 FAT3 LAMA3 ITGB2 CRB1 FAT1 CELSR1 HMCN1 JAG1 LRP6 LRP5 HAS2 TNXB | 4.49e-04 | 1077 | 96 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 4.68e-04 | 138 | 96 | 5 | GO:0030512 | |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 4.83e-04 | 78 | 96 | 4 | GO:0032508 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 4.97e-04 | 299 | 96 | 7 | GO:0060560 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.47e-04 | 218 | 96 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 5.74e-04 | 35 | 96 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | sensory organ development | SPRY2 PRICKLE1 DLL4 INHBB FAT3 CRB1 FAT1 CELSR1 JAG1 LRP6 LRP5 | 5.80e-04 | 730 | 96 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 5.86e-04 | 145 | 96 | 5 | GO:0014909 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell migration | 6.11e-04 | 83 | 96 | 4 | GO:0014911 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 6.24e-04 | 36 | 96 | 3 | GO:1904754 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 6.40e-04 | 84 | 96 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 6.43e-04 | 148 | 96 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 6.43e-04 | 148 | 96 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | bone mineralization | 6.63e-04 | 149 | 96 | 5 | GO:0030282 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.79e-04 | 412 | 96 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | DNA geometric change | 6.99e-04 | 86 | 96 | 4 | GO:0032392 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 7.30e-04 | 87 | 96 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SPRY2 PRICKLE1 SEMA5A FBN1 DKK1 IGFBP5 ADAMTS7 JAG1 LRP6 LRP5 LTBP3 NOTCH3 | 7.44e-04 | 875 | 96 | 12 | GO:0045596 |
| GeneOntologyCellularComponent | extracellular matrix | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 ADAM11 TINAGL1 EYS FBN1 FBN2 HMCN1 MEGF9 ADAMTS7 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 1.80e-10 | 656 | 98 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 ADAM11 TINAGL1 EYS FBN1 FBN2 HMCN1 MEGF9 ADAMTS7 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 1.90e-10 | 658 | 98 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 ADAM11 TINAGL1 EYS FBN1 FBN2 HMCN1 MEGF9 LTBP1 LTBP2 LTBP3 TNXB | 3.93e-10 | 530 | 98 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.08e-07 | 122 | 98 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 3.14e-07 | 13 | 98 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.30e-04 | 4 | 98 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | tenascin complex | 1.30e-04 | 4 | 98 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | insulin-like growth factor ternary complex | 1.30e-04 | 4 | 98 | 2 | GO:0042567 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 2.16e-04 | 5 | 98 | 2 | GO:1990851 | |
| GeneOntologyCellularComponent | insulin-like growth factor binding protein complex | 2.16e-04 | 5 | 98 | 2 | GO:0016942 | |
| GeneOntologyCellularComponent | growth factor complex | 5.98e-04 | 8 | 98 | 2 | GO:0036454 | |
| GeneOntologyCellularComponent | laminin complex | 9.55e-04 | 10 | 98 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 9.55e-04 | 10 | 98 | 2 | GO:0031390 | |
| HumanPheno | Duplicated collecting system | 1.27e-06 | 24 | 43 | 5 | HP:0000081 | |
| HumanPheno | Abnormal renal collecting system morphology | 4.11e-06 | 30 | 43 | 5 | HP:0004742 | |
| HumanPheno | Congenital localized absence of skin | 4.54e-05 | 9 | 43 | 3 | HP:0007383 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 6.96e-05 | 2 | 43 | 2 | HP:0005900 | |
| MousePheno | abnormal craniofacial morphology | TRPM6 SPRY2 KIF27 PRICKLE1 LAMA3 LAMB3 NELL1 FAT1 CELSR1 KMT2D FBN1 FBN2 PRSS47P DKK1 TLL1 JAG1 ARHGAP29 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP3 HYDIN | 1.29e-07 | 1372 | 76 | 24 | MP:0000428 |
| MousePheno | craniofacial phenotype | TRPM6 SPRY2 KIF27 PRICKLE1 LAMA3 LAMB3 NELL1 FAT1 CELSR1 KMT2D FBN1 FBN2 PRSS47P DKK1 TLL1 JAG1 ARHGAP29 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP3 HYDIN | 1.29e-07 | 1372 | 76 | 24 | MP:0005382 |
| MousePheno | abnormal cranium morphology | SPRY2 PRICKLE1 LAMA3 LAMB3 NELL1 CELSR1 KMT2D FBN1 FBN2 PRSS47P DKK1 SCUBE3 LRP6 LRP5 LTBP1 LTBP3 HYDIN | 1.26e-06 | 813 | 76 | 17 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | SPRY2 PRICKLE1 LAMA3 LAMB3 NELL1 CELSR1 KMT2D FBN1 FBN2 PRSS47P DKK1 SCUBE3 LRP6 LRP5 LTBP1 LTBP3 HYDIN | 1.59e-06 | 827 | 76 | 17 | MP:0002116 |
| MousePheno | abnormal head morphology | TRPM6 SPRY2 KIF27 PRICKLE1 LAMA3 LAMB3 NELL1 FAT1 KMT2D PRSS47P DKK1 TLL1 JAG1 ARHGAP29 LRP6 LTBP1 LTBP3 HAS2 HYDIN | 5.94e-06 | 1120 | 76 | 19 | MP:0000432 |
| MousePheno | absent paraxial mesoderm | 1.27e-05 | 9 | 76 | 3 | MP:0012184 | |
| MousePheno | abnormal neurocranium morphology | 1.46e-05 | 269 | 76 | 9 | MP:0000074 | |
| MousePheno | abnormal viscerocranium morphology | SPRY2 PRICKLE1 LAMA3 LAMB3 NELL1 KMT2D FBN1 FBN2 PRSS47P DKK1 LRP6 LTBP1 LTBP3 | 1.65e-05 | 593 | 76 | 13 | MP:0005274 |
| MousePheno | abnormal facial morphology | TRPM6 SPRY2 KIF27 PRICKLE1 LAMA3 LAMB3 NELL1 KMT2D PRSS47P DKK1 TLL1 JAG1 ARHGAP29 LRP6 LTBP1 LTBP3 | 2.44e-05 | 910 | 76 | 16 | MP:0003743 |
| MousePheno | abnormal jaw morphology | SPRY2 PRICKLE1 LAMA3 LAMB3 KMT2D FBN1 FBN2 PRSS47P DKK1 LRP6 LTBP1 LTBP3 | 2.64e-05 | 530 | 76 | 12 | MP:0000454 |
| MousePheno | abnormal phalanx morphology | 5.68e-05 | 76 | 76 | 5 | MP:0005306 | |
| MousePheno | embryonic lethality during organogenesis | TRPM6 ERBB3 PRICKLE1 DLL4 ENPP2 SEMA5A DDX11 SEC24D KMT2D FBN1 BRPF1 JAG1 LRP1 HAS2 DDX11L8 | 6.20e-05 | 876 | 76 | 15 | MP:0006207 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | ERBB3 DLL4 ENPP2 SEMA5A DDX11 SEC24D KMT2D FBN1 BRPF1 JAG1 LRP1 HAS2 DDX11L8 | 9.16e-05 | 700 | 76 | 13 | MP:0011098 |
| MousePheno | abnormal cardiovascular development | ERBB3 PRICKLE1 DLL4 ENPP2 SEMA5A DDX11 ADAMTS7 TLL1 JAG1 LRP5 LTBP1 HAS2 DDX11L8 NOTCH3 | 9.23e-05 | 802 | 76 | 14 | MP:0002925 |
| MousePheno | short snout | 9.50e-05 | 136 | 76 | 6 | MP:0000445 | |
| MousePheno | abnormal trabecular bone mass | 1.02e-04 | 45 | 76 | 4 | MP:0010871 | |
| MousePheno | abnormal nose morphology | 1.08e-04 | 201 | 76 | 7 | MP:0002233 | |
| MousePheno | thin neurocranium | 1.19e-04 | 18 | 76 | 3 | MP:0030279 | |
| MousePheno | small snout | 1.30e-04 | 144 | 76 | 6 | MP:0030190 | |
| MousePheno | abnormal maxilla morphology | 1.30e-04 | 144 | 76 | 6 | MP:0000455 | |
| MousePheno | poor circulation | 1.41e-04 | 19 | 76 | 3 | MP:0001633 | |
| MousePheno | decreased trabecular bone mass | 1.65e-04 | 20 | 76 | 3 | MP:0010873 | |
| MousePheno | enlarged parietal bone | 1.74e-04 | 4 | 76 | 2 | MP:0004421 | |
| MousePheno | increased collagen level | 1.74e-04 | 4 | 76 | 2 | MP:0020253 | |
| MousePheno | decreased bone mass | 2.09e-04 | 100 | 76 | 5 | MP:0004016 | |
| MousePheno | abnormal axial skeleton morphology | TRPM6 SPRY2 PRICKLE1 LAMA3 LAMB3 NELL1 CELSR1 KMT2D FBN1 FBN2 PRSS47P DKK1 SCUBE3 LRP6 LRP5 LTBP1 LTBP3 HYDIN NOTCH3 | 2.25e-04 | 1458 | 76 | 19 | MP:0002114 |
| MousePheno | abnormal germ layer morphology | 2.39e-04 | 161 | 76 | 6 | MP:0014138 | |
| MousePheno | short facial bone | 2.51e-04 | 104 | 76 | 5 | MP:0030384 | |
| MousePheno | kinked neural tube | 2.56e-04 | 57 | 76 | 4 | MP:0003400 | |
| MousePheno | abnormal heart atrium morphology | 2.62e-04 | 232 | 76 | 7 | MP:0003105 | |
| MousePheno | abnormal vertebrae development | 2.93e-04 | 59 | 76 | 4 | MP:0005225 | |
| MousePheno | pathological neovascularization | 3.00e-04 | 108 | 76 | 5 | MP:0003711 | |
| MousePheno | abnormal liver physiology | 3.13e-04 | 401 | 76 | 9 | MP:0000609 | |
| MousePheno | abnormal tooth morphology | 3.23e-04 | 318 | 76 | 8 | MP:0002100 | |
| MousePheno | abnormal lower incisor morphology | 3.26e-04 | 25 | 76 | 3 | MP:0030136 | |
| MousePheno | abnormal dental arch morphology | 3.30e-04 | 319 | 76 | 8 | MP:0030254 | |
| MousePheno | abnormal neural tube morphology | TRPM6 ERBB3 PRICKLE1 ENPP2 DDX11 CELSR1 DKK1 JAG1 LRP6 LTBP1 DDX11L8 | 3.31e-04 | 591 | 76 | 11 | MP:0002151 |
| MousePheno | kinked tail | 3.85e-04 | 114 | 76 | 5 | MP:0000585 | |
| MousePheno | abnormal mandible morphology | 3.86e-04 | 176 | 76 | 6 | MP:0000458 | |
| MousePheno | abnormal parietal bone morphology | 4.00e-04 | 64 | 76 | 4 | MP:0000109 | |
| MousePheno | abnormal bone remodeling | 4.10e-04 | 178 | 76 | 6 | MP:0002998 | |
| MousePheno | small parietal bone | 4.11e-04 | 27 | 76 | 3 | MP:0004418 | |
| MousePheno | abnormal forelimb morphology | 4.61e-04 | 182 | 76 | 6 | MP:0000550 | |
| MousePheno | abnormal craniofacial development | 4.79e-04 | 425 | 76 | 9 | MP:0003935 | |
| MousePheno | abnormal snout morphology | 4.86e-04 | 257 | 76 | 7 | MP:0000443 | |
| MousePheno | abnormal nasal bone morphology | 5.34e-04 | 69 | 76 | 4 | MP:0000102 | |
| MousePheno | abnormal hepatobiliary system physiology | 5.48e-04 | 433 | 76 | 9 | MP:0002139 | |
| MousePheno | abnormal skeleton physiology | NID2 PRICKLE1 ITGB2 NELL1 FBN1 FBN2 SCUBE3 LRP6 LRP5 LTBP3 NOTCH3 | 5.82e-04 | 632 | 76 | 11 | MP:0001533 |
| MousePheno | increased total lung capacity | 6.02e-04 | 7 | 76 | 2 | MP:0010937 | |
| MousePheno | enlarged frontal bone | 6.02e-04 | 7 | 76 | 2 | MP:0004375 | |
| MousePheno | enlarged interparietal bone | 6.02e-04 | 7 | 76 | 2 | MP:0004386 | |
| MousePheno | thin parietal bone | 6.02e-04 | 7 | 76 | 2 | MP:0030281 | |
| MousePheno | abnormal vascular development | 6.75e-04 | 542 | 76 | 10 | MP:0000259 | |
| MousePheno | abnormal ectoderm morphology | 6.84e-04 | 32 | 76 | 3 | MP:0014139 | |
| MousePheno | abnormal vertebrae morphology | 7.14e-04 | 546 | 76 | 10 | MP:0000137 | |
| MousePheno | abnormal muscle morphology | ERBB3 PRICKLE1 DLL4 INHBB FAT3 LAMA4 FBN1 FBN2 IGFBP3 TLL1 TLL2 LRP1 LTBP1 HAS2 NOTCH3 | 7.82e-04 | 1106 | 76 | 15 | MP:0002108 |
| MousePheno | increased allantois apoptosis | 8.00e-04 | 8 | 76 | 2 | MP:0003891 | |
| MousePheno | decreased Schwann cell number | 8.00e-04 | 8 | 76 | 2 | MP:0001107 | |
| MousePheno | abnormal frontal bone morphology | 8.09e-04 | 77 | 76 | 4 | MP:0000107 | |
| MousePheno | abnormal embryonic tissue morphology | TRPM6 ERBB3 PRICKLE1 DLL4 ENPP2 DDX11 CELSR1 DKK1 JAG1 ARHGAP29 LRP1 LRP6 LTBP1 HAS2 DDX11L8 | 8.58e-04 | 1116 | 76 | 15 | MP:0002085 |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 9.29e-04 | 208 | 76 | 6 | MP:0011109 | |
| MousePheno | abnormal mesenchyme morphology | 9.33e-04 | 80 | 76 | 4 | MP:0006301 | |
| MousePheno | abnormal nervous system development | TRPM6 ERBB3 KIF27 PRICKLE1 ENPP2 LAMA4 DDX11 FAT1 CELSR1 DKK1 JAG1 LRP6 LTBP1 HYDIN DDX11L8 NOTCH3 | 1.01e-03 | 1257 | 76 | 16 | MP:0003861 |
| MousePheno | iris coloboma | 1.02e-03 | 9 | 76 | 2 | MP:0010714 | |
| MousePheno | abnormal vertebral column morphology | TRPM6 SPRY2 PRICKLE1 NELL1 FBN1 FBN2 SCUBE3 LRP6 LRP5 LTBP3 HYDIN NOTCH3 | 1.04e-03 | 787 | 76 | 12 | MP:0004703 |
| MousePheno | decreased bone ossification | 1.05e-03 | 37 | 76 | 3 | MP:0020040 | |
| MousePheno | wavy neural tube | 1.05e-03 | 37 | 76 | 3 | MP:0000930 | |
| MousePheno | decreased bone mineral density | 1.07e-03 | 476 | 76 | 9 | MP:0000063 | |
| MousePheno | abnormal heart ventricle morphology | PRICKLE1 DLL4 FAT3 LAMA4 FBN1 IGFBP3 TLL1 JAG1 LRP1 SCUBE3 LTBP1 HAS2 | 1.11e-03 | 793 | 76 | 12 | MP:0005294 |
| MousePheno | abnormal somatic nervous system morphology | SPRY2 ERBB3 PRICKLE1 INHBB FAT3 LAMA4 CRB1 CELSR1 FBN2 IGFBP3 HMCN1 JAG1 LRP6 LRP5 | 1.12e-03 | 1025 | 76 | 14 | MP:0002752 |
| MousePheno | short maxilla | 1.23e-03 | 39 | 76 | 3 | MP:0000097 | |
| MousePheno | abnormal total lung capacity | 1.28e-03 | 10 | 76 | 2 | MP:0002304 | |
| MousePheno | abnormal inner ear morphology | 1.28e-03 | 303 | 76 | 7 | MP:0000026 | |
| MousePheno | abnormal blood vessel physiology | 1.31e-03 | 394 | 76 | 8 | MP:0000249 | |
| MousePheno | abnormal paraxial mesoderm morphology | 1.32e-03 | 40 | 76 | 3 | MP:0008029 | |
| MousePheno | atrial septal defect | 1.33e-03 | 88 | 76 | 4 | MP:0010403 | |
| MousePheno | abnormal bone ossification | 1.33e-03 | 395 | 76 | 8 | MP:0008271 | |
| MousePheno | abnormal presacral vertebrae morphology | 1.39e-03 | 225 | 76 | 6 | MP:0000459 | |
| MousePheno | coloboma | 1.42e-03 | 41 | 76 | 3 | MP:0005262 | |
| MousePheno | open neural tube | 1.42e-03 | 226 | 76 | 6 | MP:0000929 | |
| MousePheno | short tail | 1.45e-03 | 90 | 76 | 4 | MP:0000592 | |
| MousePheno | abnormal lung compliance | 1.52e-03 | 42 | 76 | 3 | MP:0002333 | |
| MousePheno | abnormal vasculature physiology | 1.54e-03 | 404 | 76 | 8 | MP:0031170 | |
| MousePheno | increased muscle weight | 1.55e-03 | 11 | 76 | 2 | MP:0003397 | |
| MousePheno | decreased airway resistance | 1.55e-03 | 11 | 76 | 2 | MP:0010936 | |
| MousePheno | uveal coloboma | 1.55e-03 | 11 | 76 | 2 | MP:0012533 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.69e-03 | 410 | 76 | 8 | MP:0011102 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.69e-03 | 410 | 76 | 8 | MP:0031660 | |
| MousePheno | abnormal digit morphology | 1.84e-03 | 323 | 76 | 7 | MP:0002110 | |
| MousePheno | flattened snout | 1.86e-03 | 12 | 76 | 2 | MP:0000447 | |
| MousePheno | decreased paraxial mesoderm size | 1.86e-03 | 12 | 76 | 2 | MP:0012183 | |
| MousePheno | abnormal enteric ganglia morphology | 1.86e-03 | 12 | 76 | 2 | MP:0001045 | |
| MousePheno | abnormal blood circulation | ERBB3 KIF27 DLL4 ENPP2 LAMA4 FBN1 TLL1 JAG1 LRP1 LRP5 HYDIN NOTCH3 | 1.90e-03 | 845 | 76 | 12 | MP:0002128 |
| MousePheno | abnormal cranium size | 1.91e-03 | 97 | 76 | 4 | MP:0010031 | |
| MousePheno | postnatal lethality | TRPM6 SPRY2 ERBB3 PRICKLE1 INHBB LAMA3 LAMB3 TINAGL1 FAT1 FBN1 JAG1 LRP6 LRP5 HYDIN | 1.91e-03 | 1084 | 76 | 14 | MP:0002082 |
| MousePheno | decreased body fat mass | 1.98e-03 | 46 | 76 | 3 | MP:0014143 | |
| Domain | EGF-like_CS | NID2 STAB2 DLL4 TNC FAT3 LAMA3 LAMA4 LAMB3 ADAM30 ADAM11 LRP1B ITGB2 CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 MEGF9 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 C8B TNXB FBN3 NOTCH3 | 2.73e-44 | 261 | 95 | 37 | IPR013032 |
| Domain | EGF_1 | STAB2 DLL4 TNC FAT3 LAMA3 LAMA4 LAMB3 ADAM30 ADAM11 LRP1B ITGB2 CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 MEGF9 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 C8B TNXB FBN3 NOTCH3 | 5.80e-43 | 255 | 95 | 36 | PS00022 |
| Domain | EGF_2 | NID2 STAB2 DLL4 TNC FAT3 LAMA3 LAMB3 ADAM30 ADAM11 LRP1B ITGB2 CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 MEGF9 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 C8B TNXB FBN3 NOTCH3 | 2.49e-42 | 265 | 95 | 36 | PS01186 |
| Domain | EGF-like_dom | NID2 STAB2 DLL4 TNC FAT3 LAMA3 LAMA4 ADAM30 ADAM11 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 MEGF9 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 C8B TNXB FBN3 NOTCH3 | 1.21e-41 | 249 | 95 | 35 | IPR000742 |
| Domain | EGF | NID2 STAB2 DLL4 TNC FAT3 LAMA3 LAMA4 ADAM11 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 MEGF9 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 TNXB FBN3 NOTCH3 | 3.74e-39 | 235 | 95 | 33 | SM00181 |
| Domain | EGF_3 | NID2 STAB2 DLL4 TNC FAT3 ADAM30 ADAM11 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 CSPG5 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 LTBP3 C8B TNXB FBN3 NOTCH3 | 1.78e-37 | 235 | 95 | 32 | PS50026 |
| Domain | Growth_fac_rcpt_ | NID2 ERBB3 STAB2 DLL4 TNC LAMA3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 IGFBP3 EGF IGFBP5 HMCN1 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB FBN3 NOTCH3 | 1.75e-34 | 156 | 95 | 27 | IPR009030 |
| Domain | EGF-like_Ca-bd_dom | NID2 STAB2 DLL4 FAT3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 1.05e-33 | 124 | 95 | 25 | IPR001881 |
| Domain | EGF_CA | NID2 STAB2 DLL4 FAT3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 4.48e-32 | 122 | 95 | 24 | SM00179 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 DLL4 FAT3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 8.12e-32 | 106 | 95 | 23 | IPR000152 |
| Domain | EGF_CA | NID2 FAT3 LRP1B CRB1 NELL1 EYS FAT1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 1.08e-30 | 99 | 95 | 22 | PS01187 |
| Domain | EGF | NID2 STAB2 DLL4 TNC LRP1B CRB1 EYS FAT1 CELSR1 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LRP6 LRP5 LTBP1 LTBP2 TNXB FBN3 NOTCH3 | 6.22e-30 | 126 | 95 | 23 | PF00008 |
| Domain | EGF_Ca-bd_CS | NID2 FAT3 LRP1B CRB1 NELL1 EYS FAT1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 4.74e-29 | 97 | 95 | 21 | IPR018097 |
| Domain | ASX_HYDROXYL | NID2 DLL4 FAT3 LRP1B CRB1 NELL1 EYS FAT1 CELSR1 FBN1 FBN2 EGF HMCN1 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 9.59e-29 | 100 | 95 | 21 | PS00010 |
| Domain | EGF_CA | NID2 FAT3 LRP1B NELL1 FAT1 FBN1 FBN2 EGF HMCN1 TLL1 TLL2 JAG1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 FBN3 NOTCH3 | 1.63e-26 | 86 | 95 | 19 | PF07645 |
| Domain | cEGF | 3.54e-17 | 26 | 95 | 10 | IPR026823 | |
| Domain | cEGF | 3.54e-17 | 26 | 95 | 10 | PF12662 | |
| Domain | EGF_extracell | STAB2 DLL4 TNC ADAM11 LRP1B ITGB2 NELL1 JAG1 LTBP2 TNXB NOTCH3 | 9.07e-15 | 60 | 95 | 11 | IPR013111 |
| Domain | EGF_2 | STAB2 DLL4 TNC ADAM11 LRP1B ITGB2 NELL1 JAG1 LTBP2 TNXB NOTCH3 | 9.07e-15 | 60 | 95 | 11 | PF07974 |
| Domain | TB | 1.03e-13 | 7 | 95 | 6 | PF00683 | |
| Domain | - | 4.10e-13 | 8 | 95 | 6 | 3.90.290.10 | |
| Domain | TB | 1.22e-12 | 9 | 95 | 6 | PS51364 | |
| Domain | TB_dom | 1.22e-12 | 9 | 95 | 6 | IPR017878 | |
| Domain | Laminin_G_2 | 2.23e-11 | 40 | 95 | 8 | PF02210 | |
| Domain | Ldl_recept_b | 4.29e-11 | 14 | 95 | 6 | PF00058 | |
| Domain | LDLRB | 4.29e-11 | 14 | 95 | 6 | PS51120 | |
| Domain | LamG | 5.06e-11 | 44 | 95 | 8 | SM00282 | |
| Domain | LY | 7.12e-11 | 15 | 95 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.12e-11 | 15 | 95 | 6 | IPR000033 | |
| Domain | hEGF | 7.64e-11 | 28 | 95 | 7 | PF12661 | |
| Domain | Laminin_G | 5.16e-10 | 58 | 95 | 8 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 7.81e-10 | 38 | 95 | 7 | PS50025 | |
| Domain | EGF_LAM_2 | 7.94e-09 | 30 | 95 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 7.94e-09 | 30 | 95 | 6 | PS01248 | |
| Domain | EGF_Lam | 2.13e-08 | 35 | 95 | 6 | SM00180 | |
| Domain | - | 2.81e-08 | 95 | 95 | 8 | 2.60.120.200 | |
| Domain | Laminin_EGF | 3.57e-08 | 38 | 95 | 6 | IPR002049 | |
| Domain | - | 4.21e-08 | 39 | 95 | 6 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.93e-08 | 40 | 95 | 6 | IPR023415 | |
| Domain | Ldl_recept_a | 1.02e-07 | 45 | 95 | 6 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.17e-07 | 46 | 95 | 6 | IPR011042 | |
| Domain | FBN | 1.27e-07 | 3 | 95 | 3 | IPR011398 | |
| Domain | LDLRA_1 | 1.52e-07 | 48 | 95 | 6 | PS01209 | |
| Domain | LDLRA_2 | 1.73e-07 | 49 | 95 | 6 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.73e-07 | 49 | 95 | 6 | IPR002172 | |
| Domain | LDLa | 1.73e-07 | 49 | 95 | 6 | SM00192 | |
| Domain | - | 2.02e-07 | 11 | 95 | 4 | 2.40.155.10 | |
| Domain | GFP-like | 2.02e-07 | 11 | 95 | 4 | IPR023413 | |
| Domain | EGF_3 | 3.01e-07 | 12 | 95 | 4 | PF12947 | |
| Domain | EGF_dom | 3.01e-07 | 12 | 95 | 4 | IPR024731 | |
| Domain | Laminin_EGF | 8.81e-07 | 35 | 95 | 5 | PF00053 | |
| Domain | - | 3.56e-06 | 46 | 95 | 5 | 4.10.400.10 | |
| Domain | ConA-like_dom | 1.59e-05 | 219 | 95 | 8 | IPR013320 | |
| Domain | DUF5050 | 2.56e-05 | 2 | 95 | 2 | IPR032485 | |
| Domain | LRP5/6 | 2.56e-05 | 2 | 95 | 2 | IPR017049 | |
| Domain | DUF5050 | 2.56e-05 | 2 | 95 | 2 | PF16472 | |
| Domain | PMG | 3.51e-05 | 13 | 95 | 3 | PF05287 | |
| Domain | KRTAP_PMG | 3.51e-05 | 13 | 95 | 3 | IPR007951 | |
| Domain | - | 3.74e-05 | 74 | 95 | 5 | 3.40.50.410 | |
| Domain | VWC | 4.06e-05 | 38 | 95 | 4 | SM00214 | |
| Domain | MetalloPept_cat_dom | 5.78e-05 | 81 | 95 | 5 | IPR024079 | |
| Domain | - | 5.78e-05 | 81 | 95 | 5 | 3.40.390.10 | |
| Domain | VWF_dom | 6.06e-05 | 42 | 95 | 4 | IPR001007 | |
| Domain | G2F | 7.65e-05 | 3 | 95 | 2 | SM00682 | |
| Domain | LIM3_prickle | 7.65e-05 | 3 | 95 | 2 | IPR033727 | |
| Domain | LIM2_prickle | 7.65e-05 | 3 | 95 | 2 | IPR033726 | |
| Domain | PET_prickle | 7.65e-05 | 3 | 95 | 2 | IPR033723 | |
| Domain | HAS/NodC | 7.65e-05 | 3 | 95 | 2 | IPR026107 | |
| Domain | BMP_1/tolloid-like | 7.65e-05 | 3 | 95 | 2 | IPR015446 | |
| Domain | TY | 8.23e-05 | 17 | 95 | 3 | SM00211 | |
| Domain | - | 8.23e-05 | 17 | 95 | 3 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 8.23e-05 | 17 | 95 | 3 | PS51162 | |
| Domain | Thyroglobulin_1 | 8.23e-05 | 17 | 95 | 3 | IPR000716 | |
| Domain | Thyroglobulin_1 | 8.23e-05 | 17 | 95 | 3 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 8.23e-05 | 17 | 95 | 3 | PS00484 | |
| Domain | VWC_out | 1.16e-04 | 19 | 95 | 3 | SM00215 | |
| Domain | ZINC_PROTEASE | 1.43e-04 | 98 | 95 | 5 | PS00142 | |
| Domain | VWF_A | 1.50e-04 | 99 | 95 | 5 | IPR002035 | |
| Domain | GFP | 1.53e-04 | 4 | 95 | 2 | IPR009017 | |
| Domain | G2F | 1.53e-04 | 4 | 95 | 2 | PF07474 | |
| Domain | DSL | 1.53e-04 | 4 | 95 | 2 | PF01414 | |
| Domain | G2_nidogen/fibulin_G2F | 1.53e-04 | 4 | 95 | 2 | IPR006605 | |
| Domain | DSL | 1.53e-04 | 4 | 95 | 2 | SM00051 | |
| Domain | NIDOGEN_G2 | 1.53e-04 | 4 | 95 | 2 | PS50993 | |
| Domain | DSL | 2.53e-04 | 5 | 95 | 2 | IPR001774 | |
| Domain | Laminin_aI | 2.53e-04 | 5 | 95 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.53e-04 | 5 | 95 | 2 | PF06008 | |
| Domain | Laminin_II | 2.53e-04 | 5 | 95 | 2 | PF06009 | |
| Domain | DSL | 2.53e-04 | 5 | 95 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 2.53e-04 | 5 | 95 | 2 | IPR011651 | |
| Domain | Laminin_domII | 2.53e-04 | 5 | 95 | 2 | IPR010307 | |
| Domain | MNNL | 2.53e-04 | 5 | 95 | 2 | PF07657 | |
| Domain | TSP_1 | 2.97e-04 | 63 | 95 | 4 | PF00090 | |
| Domain | TSP1 | 3.35e-04 | 65 | 95 | 4 | SM00209 | |
| Domain | TSP1_rpt | 3.35e-04 | 65 | 95 | 4 | IPR000884 | |
| Domain | TSP1 | 3.35e-04 | 65 | 95 | 4 | PS50092 | |
| Domain | PET | 3.79e-04 | 6 | 95 | 2 | PF06297 | |
| Domain | IGFBP1-6 | 3.79e-04 | 6 | 95 | 2 | IPR009168 | |
| Domain | IGFBP_1-6_chordata | 3.79e-04 | 6 | 95 | 2 | IPR022321 | |
| Domain | PET_domain | 3.79e-04 | 6 | 95 | 2 | IPR010442 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 ITGB2 FBN1 FBN2 TLL1 TLL2 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 1.38e-12 | 300 | 83 | 17 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 TNC LAMA4 COL6A5 ITGB2 FBN1 FBN2 TLL1 TLL2 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB | 2.86e-10 | 258 | 83 | 14 | MM14572 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.97e-08 | 37 | 83 | 6 | M27134 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.28e-07 | 140 | 83 | 9 | M587 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.05e-07 | 44 | 83 | 6 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.03e-07 | 25 | 83 | 5 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.11e-06 | 32 | 83 | 5 | MM14854 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.45e-06 | 15 | 83 | 4 | M27161 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.08e-06 | 39 | 83 | 5 | MM14601 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.05e-06 | 19 | 83 | 4 | MM15594 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.10e-06 | 46 | 83 | 5 | M239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.08e-05 | 8 | 83 | 3 | M47850 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 1.08e-05 | 8 | 83 | 3 | MM14976 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.29e-05 | 25 | 83 | 4 | M27879 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.72e-05 | 30 | 83 | 4 | M27216 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.88e-05 | 61 | 83 | 5 | M27103 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.22e-05 | 66 | 83 | 5 | M18 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.39e-05 | 13 | 83 | 3 | M47423 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.43e-05 | 72 | 83 | 5 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.87e-05 | 73 | 83 | 5 | MM15906 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 7.08e-05 | 38 | 83 | 4 | MM14874 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 7.85e-05 | 39 | 83 | 4 | MM14604 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.34e-05 | 76 | 83 | 5 | M27219 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 8.51e-05 | 15 | 83 | 3 | M27273 | |
| Pathway | WP_FOCAL_ADHESION | 1.15e-04 | 187 | 83 | 7 | MM15913 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.26e-04 | 17 | 83 | 3 | M666 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.26e-04 | 17 | 83 | 3 | MM14864 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.34e-04 | 84 | 83 | 5 | M7098 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.64e-04 | 47 | 83 | 4 | M646 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.86e-04 | 90 | 83 | 5 | M631 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.93e-04 | 49 | 83 | 4 | M618 | |
| Pathway | REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT | 3.39e-04 | 5 | 83 | 2 | M27144 | |
| Pathway | REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT | 3.39e-04 | 5 | 83 | 2 | MM14865 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 3.39e-04 | 5 | 83 | 2 | M48304 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 3.39e-04 | 5 | 83 | 2 | M22018 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.97e-04 | 59 | 83 | 4 | M27218 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.97e-04 | 59 | 83 | 4 | M39886 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 4.64e-04 | 26 | 83 | 3 | M39407 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 5.06e-04 | 6 | 83 | 2 | MM1543 | |
| Pathway | REACTOME_SIGNALING_BY_LRP5_MUTANTS | 5.06e-04 | 6 | 83 | 2 | M27432 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.20e-04 | 27 | 83 | 3 | M39545 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 5.35e-04 | 113 | 83 | 5 | M39669 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 5.80e-04 | 28 | 83 | 3 | M77 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.51e-04 | 118 | 83 | 5 | MM15588 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 6.51e-04 | 118 | 83 | 5 | M39852 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 7.03e-04 | 120 | 83 | 5 | MM14982 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 7.06e-04 | 7 | 83 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47805 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.12e-04 | 30 | 83 | 3 | M27772 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 8.15e-04 | 124 | 83 | 5 | M27285 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 9.37e-04 | 8 | 83 | 2 | M27433 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.03e-03 | 34 | 83 | 3 | M27405 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.04e-03 | 76 | 83 | 4 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.09e-03 | 77 | 83 | 4 | MM14670 | |
| Pathway | WP_FOCAL_ADHESION | 1.12e-03 | 199 | 83 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.12e-03 | 199 | 83 | 6 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.20e-03 | 9 | 83 | 2 | M47866 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.32e-03 | 37 | 83 | 3 | M39506 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.38e-03 | 82 | 83 | 4 | MM15922 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.57e-03 | 85 | 83 | 4 | M16441 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.79e-03 | 41 | 83 | 3 | M27778 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.82e-03 | 11 | 83 | 2 | M27372 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.82e-03 | 11 | 83 | 2 | M27882 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.82e-03 | 11 | 83 | 2 | M158 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.82e-03 | 11 | 83 | 2 | MM15478 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.96e-03 | 151 | 83 | 5 | M19428 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.00e-03 | 302 | 83 | 7 | M39719 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.05e-03 | 43 | 83 | 3 | M53 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.13e-03 | 154 | 83 | 5 | M39739 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.18e-03 | 12 | 83 | 2 | M47532 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.28e-03 | 94 | 83 | 4 | M1041 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.34e-03 | 45 | 83 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.49e-03 | 46 | 83 | 3 | MM15971 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.56e-03 | 13 | 83 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.56e-03 | 13 | 83 | 2 | MM15320 | |
| Pathway | BIOCARTA_GHRELIN_PATHWAY | 2.56e-03 | 13 | 83 | 2 | M22016 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.59e-03 | 161 | 83 | 5 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.59e-03 | 161 | 83 | 5 | M27871 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.65e-03 | 47 | 83 | 3 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.65e-03 | 47 | 83 | 3 | M7946 | |
| Pathway | WP_CANCER_PATHWAYS | 2.90e-03 | 507 | 83 | 9 | M48302 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.98e-03 | 14 | 83 | 2 | M47834 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.98e-03 | 14 | 83 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.98e-03 | 14 | 83 | 2 | MM14531 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.06e-03 | 326 | 83 | 7 | MM15917 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.16e-03 | 50 | 83 | 3 | MM14796 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 3.42e-03 | 15 | 83 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 3.42e-03 | 15 | 83 | 2 | M27608 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.42e-03 | 15 | 83 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 3.42e-03 | 15 | 83 | 2 | M27202 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.80e-03 | 339 | 83 | 7 | M39736 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 3.90e-03 | 16 | 83 | 2 | MM1500 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.90e-03 | 16 | 83 | 2 | M47424 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.90e-03 | 16 | 83 | 2 | M570 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.02e-03 | 110 | 83 | 4 | MM15977 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.25e-03 | 439 | 83 | 8 | M42563 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 4.40e-03 | 17 | 83 | 2 | M1389 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 4.40e-03 | 17 | 83 | 2 | M39389 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 4.40e-03 | 17 | 83 | 2 | M39443 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.56e-03 | 114 | 83 | 4 | MM14571 | |
| Pubmed | NID2 TNC LAMA3 LAMA4 COL6A5 TINAGL1 FBN1 FBN2 HMCN1 LTBP1 LTBP2 TNXB | 1.00e-13 | 175 | 98 | 12 | 28071719 | |
| Pubmed | 1.15e-11 | 64 | 98 | 8 | 22261194 | ||
| Pubmed | 1.27e-11 | 146 | 98 | 10 | 27068509 | ||
| Pubmed | 4.84e-11 | 167 | 98 | 10 | 22159717 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.79e-10 | 135 | 98 | 9 | 28675934 | |
| Pubmed | 1.30e-09 | 71 | 98 | 7 | 33541421 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | NID2 INHBB TNC LAMA4 TINAGL1 FBN1 IGFBP3 ADAMTS7 LTBP1 LTBP2 | 2.29e-09 | 248 | 98 | 10 | 24006456 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.08e-09 | 86 | 98 | 7 | 28327460 | |
| Pubmed | 8.88e-09 | 210 | 98 | 9 | 16537572 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.01e-08 | 26 | 98 | 5 | 34189436 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.18e-08 | 97 | 98 | 7 | 27559042 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.57e-08 | 101 | 98 | 7 | 20551380 | |
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 24639464 | ||
| Pubmed | The structural basis of DKK-mediated inhibition of Wnt/LRP signaling. | 2.17e-08 | 3 | 98 | 3 | 22589387 | |
| Pubmed | Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6. | 2.17e-08 | 3 | 98 | 3 | 22000856 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 17293099 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 10743502 | ||
| Pubmed | 2.82e-08 | 64 | 98 | 6 | 24431302 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DGCR2 TMEM59 LAMA4 LAMB3 LRP1B FAT1 CELSR1 FBN1 FBN2 TLL1 LRP1 LRP6 LRP5 LTBP1 LTBP2 LTBP3 NOTCH3 | 4.13e-08 | 1201 | 98 | 17 | 35696571 |
| Pubmed | 4.18e-08 | 34 | 98 | 5 | 23293290 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 7.90e-08 | 15 | 98 | 4 | 15895400 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 15611103 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 8.66e-08 | 4 | 98 | 3 | 25034023 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 18502762 | ||
| Pubmed | Mammalian tolloid proteinases: role in growth factor signalling. | 8.66e-08 | 4 | 98 | 3 | 27391803 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 8.66e-08 | 4 | 98 | 3 | 11104663 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 12429738 | ||
| Pubmed | Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. | 8.66e-08 | 4 | 98 | 3 | 11433302 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 12962157 | ||
| Pubmed | 8.99e-08 | 196 | 98 | 8 | 19334288 | ||
| Pubmed | 1.38e-07 | 383 | 98 | 10 | 19453261 | ||
| Pubmed | Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. | 2.16e-07 | 5 | 98 | 3 | 11448771 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 19898734 | ||
| Pubmed | Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. | 2.16e-07 | 5 | 98 | 3 | 16805831 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 34411563 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 20727496 | ||
| Pubmed | 2.75e-07 | 153 | 98 | 7 | 25037231 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 3.07e-07 | 50 | 98 | 5 | 24191021 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 3.42e-07 | 21 | 98 | 4 | 21337463 | |
| Pubmed | 4.13e-07 | 100 | 98 | 6 | 24859004 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 20613589 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 17822320 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 18254948 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 27045006 | ||
| Pubmed | Macrophage Wnt7b is critical for kidney repair and regeneration. | 4.31e-07 | 6 | 98 | 3 | 20160075 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 7.53e-07 | 7 | 98 | 3 | 17937400 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 12857724 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 10930463 | ||
| Pubmed | DGCR2 NID2 LAMA4 TINAGL1 SEC24D KMT2D FBN2 DKK1 LRP1 LRP5 LTBP3 | 9.17e-07 | 591 | 98 | 11 | 15231748 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 1.20e-06 | 8 | 98 | 3 | 23055981 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 20093360 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 15035989 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.54e-06 | 30 | 98 | 4 | 24552588 | |
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 12122015 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 16245338 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 38844137 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.57e-06 | 10 | 98 | 3 | 23665443 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 15143170 | ||
| Pubmed | Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. | 2.57e-06 | 10 | 98 | 3 | 21924256 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 32822074 | ||
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 24015274 | ||
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 9034910 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 3.52e-06 | 11 | 98 | 3 | 38303699 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.52e-06 | 11 | 98 | 3 | 21524702 | |
| Pubmed | Neural deletion of Tgfbr2 impairs angiogenesis through an altered secretome. | 3.64e-06 | 37 | 98 | 4 | 24990151 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 15465494 | ||
| Pubmed | The importance of Wnt signalling for neurodegeneration in Parkinson's disease. | 4.69e-06 | 12 | 98 | 3 | 22988876 | |
| Pubmed | Mouse prickle1, the homolog of a PCP gene, is essential for epiblast apical-basal polarity. | 4.69e-06 | 12 | 98 | 3 | 19706528 | |
| Pubmed | Microtubules enable the planar cell polarity of airway cilia. | 4.69e-06 | 12 | 98 | 3 | 23122850 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 21185284 | ||
| Pubmed | Molecular dynamics of Dkk4 modulates Wnt action and regulates meibomian gland development. | 4.69e-06 | 12 | 98 | 3 | 27864382 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 9396756 | ||
| Pubmed | 6.08e-06 | 13 | 98 | 3 | 26989192 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 6.08e-06 | 13 | 98 | 3 | 11578869 | |
| Pubmed | Expression of insulin-like growth factor binding proteins during mouse cochlear development. | 7.72e-06 | 14 | 98 | 3 | 23813480 | |
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 14757642 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12399449 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22281475 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21851253 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23498137 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32935274 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 7.86e-06 | 2 | 98 | 2 | 15963947 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25858550 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 7.86e-06 | 2 | 98 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 7.86e-06 | 2 | 98 | 2 | 26494287 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 7.86e-06 | 2 | 98 | 2 | 21440062 | |
| Pubmed | Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. | 7.86e-06 | 2 | 98 | 2 | 18632624 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15131124 | ||
| Pubmed | Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6. | 7.86e-06 | 2 | 98 | 2 | 21887268 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9321695 | ||
| Pubmed | PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors. | 7.86e-06 | 2 | 98 | 2 | 33136328 | |
| Pubmed | LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. | 7.86e-06 | 2 | 98 | 2 | 15084453 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 7.86e-06 | 2 | 98 | 2 | 20404337 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 7.86e-06 | 2 | 98 | 2 | 28669633 | |
| Pubmed | The expression profile of Jagged1 and Delta-like 4 in hepatocellular carcinoma. | 7.86e-06 | 2 | 98 | 2 | 30660174 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 7.86e-06 | 2 | 98 | 2 | 8791520 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 31165486 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19150886 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 7.86e-06 | 2 | 98 | 2 | 8307578 | |
| Interaction | CRISP2 interactions | 2.77e-08 | 40 | 93 | 6 | int:CRISP2 | |
| Interaction | IGFL3 interactions | 5.45e-08 | 75 | 93 | 7 | int:IGFL3 | |
| Interaction | NTN5 interactions | 7.44e-08 | 24 | 93 | 5 | int:NTN5 | |
| Interaction | PRG2 interactions | ZMYND19 LAMB3 TINAGL1 CELSR1 FBN2 ADAMTS7 TLL2 LRP6 LRP5 LTBP3 NOTCH3 | 8.15e-08 | 285 | 93 | 11 | int:PRG2 |
| Interaction | ZFP41 interactions | 2.46e-07 | 57 | 93 | 6 | int:ZFP41 | |
| Interaction | ZDHHC15 interactions | 1.82e-06 | 125 | 93 | 7 | int:ZDHHC15 | |
| Interaction | CFC1 interactions | 1.92e-06 | 126 | 93 | 7 | int:CFC1 | |
| Interaction | THBS1 interactions | 2.02e-06 | 127 | 93 | 7 | int:THBS1 | |
| Interaction | FBXO2 interactions | NID2 LAMA3 LAMA4 LAMB3 LRP1B TINAGL1 FBN1 FBN2 ADAMTS7 JAG1 NOTCH3 | 3.02e-06 | 411 | 93 | 11 | int:FBXO2 |
| Interaction | PRG3 interactions | 3.05e-06 | 49 | 93 | 5 | int:PRG3 | |
| Interaction | FBN1 interactions | 3.73e-06 | 51 | 93 | 5 | int:FBN1 | |
| Interaction | TIMP3 interactions | 3.74e-06 | 90 | 93 | 6 | int:TIMP3 | |
| Interaction | LTBP1 interactions | 4.25e-06 | 92 | 93 | 6 | int:LTBP1 | |
| Interaction | TAFAZZIN interactions | 5.22e-06 | 207 | 93 | 8 | int:TAFAZZIN | |
| Interaction | HOXA1 interactions | SPRY2 KRTAP13-2 KRTAP13-3 NELL1 FBN1 SUV39H1 BUD31 LTBP1 LTBP3 NOTCH3 | 5.74e-06 | 356 | 93 | 10 | int:HOXA1 |
| Interaction | ADAM30 interactions | 5.95e-06 | 56 | 93 | 5 | int:ADAM30 | |
| Interaction | EDN3 interactions | 1.08e-05 | 108 | 93 | 6 | int:EDN3 | |
| Interaction | DKKL1 interactions | 1.26e-05 | 111 | 93 | 6 | int:DKKL1 | |
| Interaction | LYZL1 interactions | 1.78e-05 | 118 | 93 | 6 | int:LYZL1 | |
| Interaction | MFAP2 interactions | 2.03e-05 | 12 | 93 | 3 | int:MFAP2 | |
| Interaction | MBD1 interactions | 2.85e-05 | 77 | 93 | 5 | int:MBD1 | |
| Interaction | PI15 interactions | 4.10e-05 | 83 | 93 | 5 | int:PI15 | |
| Interaction | PRSS37 interactions | 4.16e-05 | 15 | 93 | 3 | int:PRSS37 | |
| Interaction | DYRK1A interactions | CYLD SPRY2 ERBB3 ENPP2 TMEM59 LRP1B NELL1 KMT2D FBN1 MEGF9 LTBP3 | 4.72e-05 | 552 | 93 | 11 | int:DYRK1A |
| Interaction | SIRPD interactions | 4.87e-05 | 86 | 93 | 5 | int:SIRPD | |
| Interaction | C2CD4B interactions | 5.01e-05 | 44 | 93 | 4 | int:C2CD4B | |
| Interaction | WNT1 interactions | 5.10e-05 | 16 | 93 | 3 | int:WNT1 | |
| Interaction | SLURP1 interactions | 5.48e-05 | 144 | 93 | 6 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 5.70e-05 | 145 | 93 | 6 | int:ZNF408 | |
| Interaction | CMA1 interactions | 5.98e-05 | 46 | 93 | 4 | int:CMA1 | |
| Interaction | KLKB1 interactions | 6.17e-05 | 17 | 93 | 3 | int:KLKB1 | |
| Interaction | ODAPH interactions | 7.68e-05 | 49 | 93 | 4 | int:ODAPH | |
| Interaction | CTSG interactions | 7.84e-05 | 95 | 93 | 5 | int:CTSG | |
| Interaction | DCANP1 interactions | 8.74e-05 | 19 | 93 | 3 | int:DCANP1 | |
| Interaction | MFAP5 interactions | 9.71e-05 | 52 | 93 | 4 | int:MFAP5 | |
| Interaction | ZNF224 interactions | 1.02e-04 | 20 | 93 | 3 | int:ZNF224 | |
| Interaction | HAS2 interactions | 1.26e-04 | 4 | 93 | 2 | int:HAS2 | |
| Interaction | ADAM12 interactions | 1.49e-04 | 58 | 93 | 4 | int:ADAM12 | |
| Interaction | LYPD1 interactions | 1.49e-04 | 58 | 93 | 4 | int:LYPD1 | |
| Interaction | BMP1 interactions | 1.64e-04 | 111 | 93 | 5 | int:BMP1 | |
| Interaction | KLK3 interactions | 1.70e-04 | 60 | 93 | 4 | int:KLK3 | |
| Interaction | HRG interactions | 2.06e-04 | 63 | 93 | 4 | int:HRG | |
| Interaction | COL6A5 interactions | 2.09e-04 | 5 | 93 | 2 | int:COL6A5 | |
| Interaction | FBN2 interactions | 2.32e-04 | 65 | 93 | 4 | int:FBN2 | |
| Interaction | NCR3 interactions | 2.36e-04 | 120 | 93 | 5 | int:NCR3 | |
| Interaction | LYPD4 interactions | 2.64e-04 | 123 | 93 | 5 | int:LYPD4 | |
| Interaction | ELN interactions | 3.19e-04 | 29 | 93 | 3 | int:ELN | |
| Interaction | NMS interactions | 3.53e-04 | 30 | 93 | 3 | int:NMS | |
| Interaction | LAMC2 interactions | 3.53e-04 | 30 | 93 | 3 | int:LAMC2 | |
| Interaction | IL17F interactions | 3.89e-04 | 31 | 93 | 3 | int:IL17F | |
| Interaction | ST14 interactions | 3.96e-04 | 207 | 93 | 6 | int:ST14 | |
| Interaction | PLAUR interactions | 4.06e-04 | 135 | 93 | 5 | int:PLAUR | |
| Interaction | DKK1 interactions | 4.28e-04 | 32 | 93 | 3 | int:DKK1 | |
| Interaction | PAPPA2 interactions | 4.36e-04 | 7 | 93 | 2 | int:PAPPA2 | |
| Interaction | RGS22 interactions | 4.36e-04 | 7 | 93 | 2 | int:RGS22 | |
| Interaction | NXPH2 interactions | 4.69e-04 | 33 | 93 | 3 | int:NXPH2 | |
| Interaction | ADAM33 interactions | 4.90e-04 | 79 | 93 | 4 | int:ADAM33 | |
| Interaction | VEGFB interactions | 5.13e-04 | 34 | 93 | 3 | int:VEGFB | |
| Interaction | NDP interactions | 5.59e-04 | 35 | 93 | 3 | int:NDP | |
| Interaction | SFRP2 interactions | 5.59e-04 | 35 | 93 | 3 | int:SFRP2 | |
| Interaction | SSX6P interactions | 5.79e-04 | 8 | 93 | 2 | int:SSX6P | |
| Interaction | WNT10A interactions | 6.60e-04 | 37 | 93 | 3 | int:WNT10A | |
| Cytoband | 21q22.1 | 8.15e-05 | 39 | 98 | 3 | 21q22.1 | |
| GeneFamily | Low density lipoprotein receptors | 1.35e-07 | 13 | 69 | 4 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.12e-07 | 4 | 69 | 3 | 628 | |
| GeneFamily | Laminin subunits | 1.14e-05 | 12 | 69 | 3 | 626 | |
| GeneFamily | LIM domain containing | 7.55e-05 | 59 | 69 | 4 | 1218 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 8.57e-05 | 4 | 69 | 2 | 1184 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 2.13e-04 | 6 | 69 | 2 | 894 | |
| GeneFamily | Glycosyltransferase family 2 | 2.13e-04 | 6 | 69 | 2 | 428 | |
| GeneFamily | Insulin like growth factor binding proteins | 2.13e-04 | 6 | 69 | 2 | 1065 | |
| GeneFamily | Cadherin related | 1.88e-03 | 17 | 69 | 2 | 24 | |
| GeneFamily | Fibrinogen C domain containing | 4.07e-03 | 25 | 69 | 2 | 554 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.74e-03 | 27 | 69 | 2 | 47 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.44e-03 | 34 | 69 | 2 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 8.32e-03 | 36 | 69 | 2 | 492 | |
| GeneFamily | Keratin associated proteins | 8.37e-03 | 109 | 69 | 3 | 619 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 TNC LAMA3 LAMA4 LAMB3 TINAGL1 NELL1 EYS FBN1 FBN2 IGFBP3 IGFBP5 HMCN1 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 2.42e-20 | 196 | 97 | 18 | M3008 |
| Coexpression | NABA_MATRISOME | NID2 INHBB TNC MUC19 LAMA3 LAMA4 LAMB3 SEMA5A ADAM30 COL6A5 ADAM11 TINAGL1 NELL1 EYS FBN1 FBN2 IGFBP3 EGF IGFBP5 HMCN1 MEGF9 ADAMTS7 CSPG5 TLL1 TLL2 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 2.75e-20 | 1026 | 97 | 31 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 TINAGL1 NELL1 EYS FBN1 FBN2 IGFBP3 IGFBP5 HMCN1 LTBP1 LTBP2 LTBP3 TNXB FBN3 | 4.47e-19 | 275 | 97 | 19 | M5884 |
| Coexpression | NABA_MATRISOME | NID2 INHBB TNC MUC19 LAMA3 LAMA4 LAMB3 SEMA5A ADAM30 COL6A5 ADAM11 TINAGL1 NELL1 FBN1 FBN2 IGFBP3 EGF IGFBP5 HMCN1 MEGF9 ADAMTS7 CSPG5 TLL1 TLL2 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB | 2.24e-18 | 1008 | 97 | 29 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 TNC LAMA3 LAMA4 LAMB3 TINAGL1 NELL1 FBN1 FBN2 IGFBP3 IGFBP5 HMCN1 LTBP1 LTBP2 LTBP3 TNXB | 1.58e-17 | 191 | 97 | 16 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | NID2 TNC LAMA3 LAMA4 LAMB3 COL6A5 TINAGL1 NELL1 FBN1 FBN2 IGFBP3 IGFBP5 HMCN1 LTBP1 LTBP2 LTBP3 TNXB | 1.81e-16 | 270 | 97 | 17 | MM17057 |
| Coexpression | HAY_BONE_MARROW_STROMAL | NID2 INHBB TNC ENPP2 FAT3 TMEM59 LAMA4 TINAGL1 FAT1 FBN1 IGFBP3 IGFBP5 TLL1 JAG1 PRICKLE2 LTBP2 HAS2 NOTCH3 | 3.92e-10 | 767 | 97 | 18 | M39209 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | SPRY2 INHBB TNC ENPP2 FAT3 LAMA4 CRB1 FAT1 CELSR1 CSPG5 JAG1 DNAI2 LRP1 LTBP1 HAS2 HYDIN | 6.66e-10 | 600 | 97 | 16 | M39055 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.61e-09 | 40 | 97 | 6 | M5887 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | INHBB ENPP2 FAT3 MUC19 LRP1B CRB1 FAT1 CELSR1 IGFBP5 BCO2 CSPG5 LRP1 HAS2 HYDIN | 2.63e-08 | 574 | 97 | 14 | M39056 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | PRICKLE1 ENPP2 LAMA3 LAMB3 SEMA5A TINAGL1 SEC24D IGFBP3 JAG1 PRICKLE2 LRP1 HAS2 | 2.12e-07 | 479 | 97 | 12 | M2573 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | NID2 TNC LAMA4 SEC24D FAT1 FBN1 IGFBP3 IGFBP5 HMCN1 JAG1 LTBP1 LTBP2 HAS2 NOTCH3 | 2.14e-07 | 681 | 97 | 14 | M39175 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | PRICKLE1 ENPP2 LAMA3 LAMB3 SEMA5A TINAGL1 SEC24D IGFBP3 JAG1 PRICKLE2 LRP1 HAS2 | 2.31e-07 | 483 | 97 | 12 | MM1082 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 2.31e-07 | 235 | 97 | 9 | M2256 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | TRPM6 NID2 ERBB3 DLL4 INHBB ABLIM3 NELL1 IGFBP5 HMCN1 ADAMTS7 TLL1 TLL2 JAG1 ARHGAP29 SCUBE3 LRP5 HAS3 | 3.91e-07 | 1074 | 97 | 17 | M1941 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 4.91e-07 | 257 | 97 | 9 | M13867 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 5.05e-07 | 337 | 97 | 10 | M13206 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 7.01e-07 | 439 | 97 | 11 | M39054 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 7.59e-07 | 85 | 97 | 6 | M45761 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.08e-07 | 200 | 97 | 8 | M5930 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | LAMA4 SEC24D FBN1 FBN2 IGFBP5 HMCN1 JAG1 ARHGAP29 HAS2 NOTCH3 | 1.68e-06 | 385 | 97 | 10 | M39264 |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.71e-06 | 54 | 97 | 5 | M4737 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | INHBB ENPP2 LAMA4 ABLIM3 FBN1 IGFBP3 IGFBP5 ARHGAP29 LRP1 LTBP2 NOTCH3 | 2.73e-06 | 505 | 97 | 11 | M39167 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 6.90e-06 | 124 | 97 | 6 | M45686 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 7.09e-06 | 268 | 97 | 8 | M45796 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 7.51e-06 | 34 | 97 | 4 | M14043 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 8.45e-06 | 35 | 97 | 4 | MM17054 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 8.49e-06 | 364 | 97 | 9 | M39057 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 9.46e-06 | 131 | 97 | 6 | M40316 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 1.69e-05 | 145 | 97 | 6 | M14098 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | INHBB MUC19 SEMA5A ADAM30 ADAM11 EGF MEGF9 ADAMTS7 CSPG5 TLL1 TLL2 SCUBE3 | 1.82e-05 | 738 | 97 | 12 | MM17058 |
| Coexpression | BMI1_DN.V1_UP | 1.82e-05 | 147 | 97 | 6 | M2782 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | INHBB MUC19 SEMA5A ADAM30 ADAM11 EGF MEGF9 ADAMTS7 CSPG5 TLL1 TLL2 SCUBE3 | 2.16e-05 | 751 | 97 | 12 | M5885 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.66e-05 | 16 | 97 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.66e-05 | 16 | 97 | 3 | M2207 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.22e-05 | 17 | 97 | 3 | M47995 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 3.33e-05 | 242 | 97 | 7 | M12816 | |
| Coexpression | JONES_OVARY_PERICYTE | 4.41e-05 | 172 | 97 | 6 | M48351 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 4.56e-05 | 19 | 97 | 3 | M12084 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 5.20e-05 | 55 | 97 | 4 | MM397 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 5.35e-05 | 20 | 97 | 3 | MM17053 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 5.37e-05 | 261 | 97 | 7 | M1834 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 7.62e-05 | 276 | 97 | 7 | M3063 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN | 7.67e-05 | 190 | 97 | 6 | M9428 | |
| Coexpression | TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL | 7.82e-05 | 61 | 97 | 4 | M41672 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.25e-05 | 23 | 97 | 3 | M48001 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | ERBB3 LAMB3 SPIRE1 ITGB2 KLHL3 CELSR1 ADAMTS7 LRP1 LRP5 LTBP2 NOTCH3 | 9.26e-05 | 740 | 97 | 11 | M41202 |
| Coexpression | RB_DN.V1_DN | 9.57e-05 | 123 | 97 | 5 | M2799 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN | 1.02e-04 | 200 | 97 | 6 | M3450 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 1.13e-04 | 294 | 97 | 7 | M1804 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 1.27e-04 | 69 | 97 | 4 | M1145 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.35e-04 | 27 | 97 | 3 | M47994 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 1.36e-04 | 211 | 97 | 6 | M12225 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 | 1.50e-04 | 72 | 97 | 4 | M15699 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.67e-04 | 29 | 97 | 3 | MM17055 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 | 1.75e-04 | 75 | 97 | 4 | MM868 | |
| Coexpression | MEL18_DN.V1_UP | 1.82e-04 | 141 | 97 | 5 | M2784 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS | 1.88e-04 | 142 | 97 | 5 | M40152 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 1.94e-04 | 77 | 97 | 4 | M19128 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 | 2.04e-04 | 78 | 97 | 4 | MM867 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 2.09e-04 | 325 | 97 | 7 | M39053 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 2.22e-04 | 437 | 97 | 8 | M15981 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 2.44e-04 | 235 | 97 | 6 | M5311 | |
| Coexpression | SCHOEN_NFKB_SIGNALING | 2.71e-04 | 34 | 97 | 3 | M1983 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 2.71e-04 | 84 | 97 | 4 | M15484 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN | 2.84e-04 | 85 | 97 | 4 | M7012 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 2.85e-04 | 242 | 97 | 6 | M2128 | |
| Coexpression | JONES_OVARY_MACROPHAGE | 2.92e-04 | 243 | 97 | 6 | M48355 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.95e-04 | 35 | 97 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.21e-04 | 36 | 97 | 3 | MM1212 | |
| Coexpression | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS | 3.48e-04 | 37 | 97 | 3 | M12802 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 3.55e-04 | 163 | 97 | 5 | M2769 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | NID2 PRICKLE1 DLL4 LAMA3 NELL1 FBN1 FBN2 DKK1 IGFBP5 TLL1 TLL2 LTBP2 | 4.38e-04 | 1035 | 97 | 12 | M9898 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL | 4.43e-04 | 171 | 97 | 5 | M45687 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 4.80e-04 | 9 | 97 | 2 | M9630 | |
| Coexpression | WINZEN_DEGRADED_VIA_KHSRP | 5.27e-04 | 100 | 97 | 4 | M2352 | |
| Coexpression | BENPORATH_NOS_TARGETS | 5.45e-04 | 179 | 97 | 5 | M14573 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.45e-04 | 179 | 97 | 5 | M39308 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | KRTAP13-2 KRTAP13-3 FBN2 GPRC5D LTBP1 LTBP2 HAS3 KRTAP13-1 RIMS2 | 5.52e-04 | 630 | 97 | 9 | MM1038 |
| Coexpression | HALMOS_CEBPA_TARGETS_DN | 6.23e-04 | 45 | 97 | 3 | M8604 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 6.33e-04 | 105 | 97 | 4 | M12602 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 6.79e-04 | 107 | 97 | 4 | M4913 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_UP | 7.54e-04 | 110 | 97 | 4 | M8831 | |
| Coexpression | HU_FETAL_RETINA_RPE | 7.55e-04 | 291 | 97 | 6 | M39271 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYLD MUC19 LAMA3 ABLIM3 LRP1B NELL1 MEGF9 CSPG5 TLL1 PRICKLE2 RIMS2 HYDIN | 7.86e-04 | 1106 | 97 | 12 | M39071 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_708_5P_GENES | 8.00e-04 | 49 | 97 | 3 | MM17508 | |
| Coexpression | DITTMER_PTHLH_TARGETS_UP | 8.34e-04 | 113 | 97 | 4 | M11090 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_R848_DC_DN | 8.40e-04 | 197 | 97 | 5 | M4694 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 8.78e-04 | 199 | 97 | 5 | M4886 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | 8.78e-04 | 199 | 97 | 5 | M3479 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 8.78e-04 | 199 | 97 | 5 | M7319 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 8.78e-04 | 199 | 97 | 5 | M3641 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 8.78e-04 | 199 | 97 | 5 | M7414 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 8.90e-04 | 115 | 97 | 4 | M45752 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 8.90e-04 | 115 | 97 | 4 | M19068 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP | 8.98e-04 | 200 | 97 | 5 | M6403 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 8.98e-04 | 200 | 97 | 5 | M6480 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 8.98e-04 | 200 | 97 | 5 | M5216 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 8.98e-04 | 200 | 97 | 5 | M3413 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 8.98e-04 | 200 | 97 | 5 | M3488 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | NID2 SPRY2 TNC ENPP2 LAMA4 SEMA5A SEC24D FAT1 FBN1 IGFBP3 IGFBP5 JAG1 ARHGAP29 LRP1 LTBP2 HAS2 TNXB NOTCH3 | 1.31e-12 | 455 | 94 | 18 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | NID2 SPRY2 TNC ENPP2 LAMA4 SEMA5A COL6A5 SEC24D FAT1 FBN1 IGFBP5 JAG1 ARHGAP29 LRP1 LTBP1 HAS2 TNXB | 1.03e-11 | 445 | 94 | 17 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | SPRY2 TNC ENPP2 LAMA4 SEMA5A SEC24D FAT1 FBN1 IGFBP3 IGFBP5 HMCN1 ARHGAP29 LRP1 LTBP1 LTBP3 TNXB NOTCH3 | 2.12e-11 | 466 | 94 | 17 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | TNC ENPP2 LAMA4 SEMA5A COL6A5 TINAGL1 SEC24D FAT1 FBN1 IGFBP3 IGFBP5 JAG1 ARHGAP29 LRP1 TNXB NOTCH3 | 1.41e-10 | 453 | 94 | 16 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | NID2 STAB2 DLL4 TNC ENPP2 LAMA4 TINAGL1 FBN1 IGFBP5 HMCN1 TLL1 JAG1 ARHGAP29 LTBP1 LTBP2 | 8.89e-10 | 439 | 94 | 15 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | STAB2 DLL4 TNC ENPP2 LAMA4 SEMA5A TINAGL1 FBN1 IGFBP5 HMCN1 TLL1 JAG1 ARHGAP29 LTBP1 LTBP2 | 1.25e-09 | 450 | 94 | 15 | GSM777063_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | NID2 TNC ENPP2 FAT3 LAMA4 SPIRE1 SEMA5A CELSR1 FBN1 FBN2 DKK1 JAG1 SUV39H1 SCUBE3 LTBP1 HAS2 HAS3 CDCA7L | 8.49e-09 | 783 | 94 | 18 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | NID2 TNC ENPP2 FAT3 LAMA4 SEMA5A NELL1 FBN1 FBN2 IGFBP5 HMCN1 JAG1 SUV39H1 SCUBE3 LTBP1 HAS2 CDCA7L | 2.81e-08 | 749 | 94 | 17 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 5.02e-08 | 165 | 94 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 5.29e-08 | 166 | 94 | 9 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | NID2 ENPP2 LAMA4 SEMA5A FBN2 DKK1 JAG1 SUV39H1 SCUBE3 LTBP1 HAS3 CDCA7L | 1.91e-07 | 398 | 94 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | TNC ENPP2 LAMA4 FBN1 IGFBP3 IGFBP5 HMCN1 ARHGAP29 LRP1 LTBP1 HAS2 TNXB | 5.17e-07 | 437 | 94 | 12 | GSM777046_500 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 6.57e-07 | 291 | 94 | 10 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | NID2 DLL4 ENPP2 LAMA3 LAMA4 SEMA5A TINAGL1 IGFBP3 TLL1 JAG1 ARHGAP29 LTBP2 | 8.67e-07 | 459 | 94 | 12 | GSM777037_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 3.15e-06 | 91 | 94 | 6 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 4.07e-06 | 54 | 94 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.58e-06 | 97 | 94 | 6 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | ERBB3 PRICKLE1 TNC ENPP2 SEMA5A FBN2 IGFBP3 DKK1 HMCN1 MICALL2 MEGF9 TLL1 LTBP1 HAS3 RIMS2 | 4.67e-06 | 850 | 94 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | DLL4 ENPP2 LAMA3 LAMA4 SEMA5A TINAGL1 IGFBP3 TLL1 JAG1 ARHGAP29 LTBP2 | 5.52e-06 | 456 | 94 | 11 | GSM777032_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 5.64e-06 | 370 | 94 | 10 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.02e-05 | 65 | 94 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.28e-05 | 175 | 94 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 1.49e-05 | 249 | 94 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | NID2 LAMA4 SEMA5A ITGB2 DDX11 NELL1 CELSR1 DKK1 TLL1 JAG1 SCUBE3 LTBP1 HAS3 RIMS2 | 1.80e-05 | 836 | 94 | 14 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 1.99e-05 | 428 | 94 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 2.12e-05 | 431 | 94 | 10 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.13e-05 | 37 | 94 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | NID2 LAMA4 LAMB3 SEMA5A ABLIM3 TINAGL1 FBN1 IGFBP3 HMCN1 ARHGAP29 LRP1 SCUBE3 LTBP2 HAS2 TNXB | 2.37e-05 | 975 | 94 | 15 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | TNC ENPP2 FAT3 LAMA4 NELL1 FBN2 HMCN1 MEGF9 JAG1 LTBP1 HAS2 CDCA7L | 2.39e-05 | 636 | 94 | 12 | gudmap_kidney_P2_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.23e-05 | 202 | 94 | 7 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ENPP2 LAMA3 LAMA4 SEMA5A IGFBP3 DKK1 HMCN1 MICALL2 MEGF9 JAG1 LTBP1 HAS3 RIMS2 | 3.36e-05 | 769 | 94 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200 | 3.54e-05 | 42 | 94 | 4 | gudmap_developingKidney_e15.5_S-shaped body_200_k4 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#2_top-relative-expression-ranked_500 | 3.58e-05 | 139 | 94 | 6 | gudmap_kidney_e10.5_UretericTip_HoxB7_k2_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 3.58e-05 | 139 | 94 | 6 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.78e-05 | 207 | 94 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.49e-05 | 377 | 94 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | INHBB TNC FAT3 SEMA5A TINAGL1 SEC24D FAT1 FBN1 IGFBP3 DKK1 IGFBP5 HMCN1 LRP1 | 4.60e-05 | 793 | 94 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.72e-05 | 146 | 94 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 5.09e-05 | 148 | 94 | 6 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 5.28e-05 | 385 | 94 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ERBB3 TNC FAT3 LAMA3 LAMA4 LAMB3 SEMA5A CELSR1 IGFBP5 HMCN1 ADAMTS7 TLL1 PRICKLE2 | 5.43e-05 | 806 | 94 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_1000 | LAMA4 TUT1 DDX11 NELL1 CELSR1 FBN2 DKK1 JAG1 SCUBE3 LTBP1 HAS2 ZNF653 CDCA7L | 5.93e-05 | 813 | 94 | 13 | gudmap_developingKidney_e12.5_renal vesicle_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 6.79e-05 | 96 | 94 | 5 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.14e-05 | 97 | 94 | 5 | GSM777046_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.23e-05 | 311 | 94 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 7.49e-05 | 98 | 94 | 5 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_200 | 8.29e-05 | 52 | 94 | 4 | gudmap_developingKidney_e12.5_renal vesicle_200_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.63e-05 | 236 | 94 | 7 | gudmap_kidney_P3_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 8.71e-05 | 411 | 94 | 9 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | NID2 ENPP2 SEMA5A LRP1B CRB1 NELL1 FBN1 FBN2 IGFBP3 DKK1 IGFBP5 HMCN1 SCUBE3 LTBP2 HAS2 | 8.80e-05 | 1094 | 94 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_100 | 9.07e-05 | 20 | 94 | 3 | gudmap_developingKidney_e15.5_S-shaped body_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | STAB2 INHBB LAMA4 DDX11 CELSR1 DKK1 TLL1 PRICKLE2 SCUBE3 LTBP1 HAS2 HAS3 RIMS2 | 9.86e-05 | 855 | 94 | 13 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.26e-04 | 337 | 94 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#1_top-relative-expression-ranked_500 | 1.30e-04 | 110 | 94 | 5 | gudmap_developingKidney_e15.5_Podocyte cells_500_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | INHBB TNC FAT3 SEMA5A FAT1 FBN1 FBN2 IGFBP3 IGFBP5 HMCN1 JAG1 LRP1 | 1.45e-04 | 768 | 94 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | placenta | 1.60e-04 | 349 | 94 | 8 | placenta | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.61e-04 | 261 | 94 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | CYLD NID2 FAT3 COL6A5 SEC24D FBN1 IGFBP5 HMCN1 LRP1 LTBP2 LTBP3 TNXB | 1.63e-04 | 778 | 94 | 12 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 1.65e-04 | 62 | 94 | 4 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.65e-04 | 62 | 94 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ENPP2 FAT3 SEMA5A TMEM213 TINAGL1 SEC24D FBN1 IGFBP5 JAG1 PRICKLE2 SCUBE3 LTBP1 NOTCH3 | 1.73e-04 | 905 | 94 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_100 | 1.76e-04 | 63 | 94 | 4 | gudmap_kidney_P0_CapMes_Crym_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.77e-04 | 354 | 94 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.83e-04 | 356 | 94 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.87e-04 | 357 | 94 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.02e-04 | 361 | 94 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.07e-04 | 191 | 94 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.10e-04 | 122 | 94 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 2.25e-04 | 194 | 94 | 6 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 2.27e-04 | 124 | 94 | 5 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.34e-04 | 369 | 94 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.36e-04 | 125 | 94 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 2.38e-04 | 196 | 94 | 6 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | ENPP2 TMEM59 SEMA5A SEC24D FAT1 FBN1 IGFBP3 DKK1 IGFBP5 TEX29 LRP1 SCUBE3 | 2.48e-04 | 814 | 94 | 12 | JC_fibro_2500_K5 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.53e-04 | 281 | 94 | 7 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.53e-04 | 281 | 94 | 7 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | PRICKLE1 FAT3 LAMA4 SEMA5A NELL1 SEC24D FAT1 FBN1 FBN2 HMCN1 ADAMTS7 PRICKLE2 LRP1 HAS2 ZNF653 | 2.61e-04 | 1208 | 94 | 15 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.69e-04 | 478 | 94 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.83e-04 | 130 | 94 | 5 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TNC ENPP2 FAT3 SEMA5A FBN2 IGFBP3 DKK1 HMCN1 MEGF9 TLL1 JAG1 LTBP1 | 3.16e-04 | 836 | 94 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.26e-04 | 293 | 94 | 7 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_500 | 3.27e-04 | 74 | 94 | 4 | gudmap_developingKidney_e15.5_S-shaped body_500_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 3.28e-04 | 388 | 94 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 3.33e-04 | 294 | 94 | 7 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.33e-04 | 492 | 94 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | FAT3 SEMA5A LRP1B CRB1 CELSR1 DKK1 IGFBP5 CSPG5 RECQL5 ZC3HAV1L ARHGAP29 SCUBE3 HAS2 CDCA7L FBN3 | 3.60e-04 | 1245 | 94 | 15 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.62e-04 | 212 | 94 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_100 | 3.62e-04 | 76 | 94 | 4 | gudmap_developingKidney_e12.5_renal vesicle_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 4.16e-04 | 33 | 94 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.57e-04 | 310 | 94 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.66e-04 | 311 | 94 | 7 | gudmap_developingKidney_e13.5_podocyte cells_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 4.82e-04 | 146 | 94 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 4.84e-04 | 82 | 94 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 4.97e-04 | 147 | 94 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 5.12e-04 | 415 | 94 | 8 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 5.13e-04 | 148 | 94 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 5.29e-04 | 639 | 94 | 10 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#4_top-relative-expression-ranked_500 | 5.30e-04 | 84 | 94 | 4 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k4_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 5.30e-04 | 84 | 94 | 4 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.54e-04 | 85 | 94 | 4 | GSM777067_100 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | NID2 TNC SEMA5A COL6A5 FBN1 DKK1 MICALL2 LRP1 LRP6 LTBP1 HAS2 TNXB | 2.34e-14 | 199 | 98 | 12 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | NID2 TNC FAT3 SEMA5A FBN1 IGFBP3 IGFBP5 HMCN1 JAG1 LTBP2 TNXB | 7.27e-13 | 198 | 98 | 11 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TNC LAMA4 SEMA5A COL6A5 NELL1 FBN1 MICALL2 LRP1 LTBP1 HAS2 TNXB | 8.12e-13 | 200 | 98 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | NID2 TNC LAMA4 COL6A5 NELL1 FBN1 MICALL2 LRP1 LTBP1 HAS2 TNXB | 8.12e-13 | 200 | 98 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-12 | 160 | 98 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-12 | 160 | 98 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-11 | 195 | 98 | 10 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-11 | 198 | 98 | 10 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.28e-11 | 199 | 98 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL6A5 FBN1 IGFBP5 HMCN1 PRICKLE2 LRP1 LTBP1 LTBP2 HAS2 TNXB | 2.40e-11 | 200 | 98 | 10 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.40e-11 | 200 | 98 | 10 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-10 | 173 | 98 | 9 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.49e-10 | 187 | 98 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-10 | 188 | 98 | 9 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-10 | 191 | 98 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-10 | 191 | 98 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-10 | 191 | 98 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-10 | 192 | 98 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.41e-10 | 192 | 98 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.41e-10 | 192 | 98 | 9 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-10 | 193 | 98 | 9 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-10 | 194 | 98 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-10 | 194 | 98 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-10 | 196 | 98 | 9 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-10 | 196 | 98 | 9 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.54e-10 | 197 | 98 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.54e-10 | 197 | 98 | 9 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.54e-10 | 197 | 98 | 9 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.54e-10 | 197 | 98 | 9 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.05e-10 | 199 | 98 | 9 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.05e-10 | 199 | 98 | 9 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.05e-10 | 199 | 98 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.05e-10 | 199 | 98 | 9 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.05e-10 | 199 | 98 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 6.05e-10 | 199 | 98 | 9 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.05e-10 | 199 | 98 | 9 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-10 | 200 | 98 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-10 | 200 | 98 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-10 | 200 | 98 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-10 | 200 | 98 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-10 | 200 | 98 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-09 | 162 | 98 | 8 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-09 | 181 | 98 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-09 | 181 | 98 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.09e-09 | 182 | 98 | 8 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-09 | 182 | 98 | 8 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-09 | 183 | 98 | 8 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-09 | 183 | 98 | 8 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.14e-09 | 188 | 98 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-09 | 189 | 98 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.52e-09 | 189 | 98 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.52e-09 | 189 | 98 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-09 | 190 | 98 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 191 | 98 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 191 | 98 | 8 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-08 | 191 | 98 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 191 | 98 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 191 | 98 | 8 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 191 | 98 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.03e-08 | 191 | 98 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-08 | 192 | 98 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-08 | 192 | 98 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-08 | 192 | 98 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-08 | 192 | 98 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-08 | 192 | 98 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 192 | 98 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.12e-08 | 193 | 98 | 8 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-08 | 193 | 98 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-08 | 193 | 98 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-08 | 193 | 98 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.12e-08 | 193 | 98 | 8 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-08 | 193 | 98 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-08 | 194 | 98 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-08 | 194 | 98 | 8 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-08 | 194 | 98 | 8 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-08 | 195 | 98 | 8 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| Computational | Adhesion molecules. | 7.75e-10 | 141 | 66 | 11 | MODULE_122 | |
| Computational | DRG (dorsal root ganglia) genes. | ERBB3 TNC ENPP2 LAMA4 ABLIM3 FAT1 FBN1 IGFBP3 MEGF9 LRP1 LTBP1 LTBP2 TNXB NOTCH3 | 6.21e-08 | 384 | 66 | 14 | MODULE_2 |
| Computational | Metal / Ca ion binding. | 1.40e-06 | 133 | 66 | 8 | MODULE_324 | |
| Computational | Ovary genes. | NID2 TNC ENPP2 FAT1 FBN1 IGFBP3 LRP1 LTBP1 LTBP2 TNXB NOTCH3 | 1.29e-05 | 368 | 66 | 11 | MODULE_1 |
| Computational | IGFBPs. | 4.68e-05 | 12 | 66 | 3 | MODULE_190 | |
| Computational | Placenta genes. | ERBB3 ENPP2 FBN2 IGFBP3 JAG1 RECQL5 LRP1 LTBP1 LTBP2 TNXB NOTCH3 | 1.06e-04 | 463 | 66 | 11 | MODULE_38 |
| Computational | Genes in the cancer module 474. | 1.41e-04 | 17 | 66 | 3 | MODULE_474 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 50 | 66 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Computational | Spinal cord (neuro-development) genes. | 3.29e-04 | 360 | 66 | 9 | MODULE_12 | |
| Computational | Genes in the cancer module 100. | DGCR2 NID2 INHBB TNC ENPP2 ABLIM3 FAT1 IGFBP3 MEGF9 CSPG5 RIMS2 | 4.29e-04 | 544 | 66 | 11 | MODULE_100 |
| Computational | ECM and collagens. | 4.37e-04 | 225 | 66 | 7 | MODULE_47 | |
| Computational | CNS genes. | DGCR2 NID2 INHBB TNC ENPP2 ABLIM3 FAT1 IGFBP3 MEGF9 CSPG5 RIMS2 | 4.42e-04 | 546 | 66 | 11 | MODULE_137 |
| Computational | Genes in the cancer module 66. | DGCR2 NID2 INHBB TNC ENPP2 ABLIM3 FAT1 IGFBP3 MEGF9 CSPG5 RIMS2 | 4.85e-04 | 552 | 66 | 11 | MODULE_66 |
| Computational | Intermediate filaments and keratins. | 1.44e-03 | 80 | 66 | 4 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.44e-03 | 80 | 66 | 4 | MODULE_297 | |
| Computational | Genes in the cancer module 412. | 2.77e-03 | 13 | 66 | 2 | MODULE_412 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.14e-03 | 48 | 66 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.53e-03 | 50 | 66 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.53e-03 | 50 | 66 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.53e-03 | 50 | 66 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.53e-03 | 50 | 66 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.53e-03 | 50 | 66 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA | |
| Drug | lead stearate | 6.13e-08 | 84 | 95 | 7 | CID000061258 | |
| Drug | chondroitin sulfate | TNC LAMA3 LAMA4 SEMA5A DDX11 EGF ADAMTS7 CSPG5 LTBP1 HAS2 HAS3 TNXB | 1.52e-07 | 413 | 95 | 12 | CID000024766 |
| Drug | Rgd Peptide | 7.14e-07 | 239 | 95 | 9 | CID000104802 | |
| Drug | pyrachlostrobin | NID2 TNC ADAM11 ITGB2 TINAGL1 FAT1 CELSR1 FBN1 IGFBP3 IGFBP5 LRP5 LTBP1 LTBP2 LTBP3 NOTCH3 | 1.29e-06 | 811 | 95 | 15 | ctd:C513428 |
| Drug | hyaluronan | 1.58e-06 | 263 | 95 | 9 | CID000024759 | |
| Drug | funiferine N-oxide | 1.88e-06 | 49 | 95 | 5 | CID000191631 | |
| Drug | Gdrgdsp | 6.45e-06 | 109 | 95 | 6 | CID000115346 | |
| Drug | methoxyresorufin | 1.03e-05 | 69 | 95 | 5 | CID000119220 | |
| Drug | 17-hydroxyprogesterone | 1.29e-05 | 123 | 95 | 6 | CID000006238 | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 1.55e-05 | 191 | 95 | 7 | 1211_UP | |
| Drug | rapamycin; Down 200; 0.1uM; MCF7; HG-U133A | 1.90e-05 | 197 | 95 | 7 | 326_DN | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 5664_UP | |
| Drug | Milrinone [78415-72-2]; Up 200; 19uM; PC3; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 5856_UP | |
| Drug | ptaquiloside | 2.01e-05 | 133 | 95 | 6 | ctd:C043680 | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 2498_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A | 2.02e-05 | 199 | 95 | 7 | 365_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.77e-05 | 155 | 95 | 6 | 6817_DN | |
| Drug | kalinin | 8.24e-05 | 55 | 95 | 4 | CID000032518 | |
| Drug | Vanadates | CYLD SPRY2 PRICKLE1 INHBB TNC ENPP2 LAMB3 ABLIM3 EGF TLL1 JAG1 PRICKLE2 LRP1 LTBP1 LTBP2 LTBP3 | 9.10e-05 | 1302 | 95 | 16 | ctd:D014638 |
| Drug | Lysophosphatidylcholines | 1.02e-04 | 22 | 95 | 3 | ctd:D008244 | |
| Drug | AC1L1EPA | 1.03e-04 | 4 | 95 | 2 | CID000028140 | |
| Drug | 9a-d | 1.03e-04 | 4 | 95 | 2 | CID000128962 | |
| Drug | 3-ethylpyridine | 1.03e-04 | 4 | 95 | 2 | CID000010823 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.06e-04 | 179 | 95 | 6 | 5590_UP | |
| Drug | AC1L9INI | 1.09e-04 | 59 | 95 | 4 | CID000445839 | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.09e-04 | 180 | 95 | 6 | 2410_UP | |
| Drug | Sikvav | 1.34e-04 | 24 | 95 | 3 | CID005487517 | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.38e-04 | 188 | 95 | 6 | 865_UP | |
| Drug | 8-Bromo Cyclic Adenosine Monophosphate | 1.47e-04 | 693 | 95 | 11 | ctd:D015124 | |
| Drug | tyrphostin RG13022 | 1.51e-04 | 25 | 95 | 3 | CID000005060 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.55e-04 | 192 | 95 | 6 | 3804_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 1.60e-04 | 193 | 95 | 6 | 462_DN | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 6424_UP | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 2804_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 3078_UP | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 2152_UP | |
| Drug | RG 14921 | 1.71e-04 | 5 | 95 | 2 | CID000197517 | |
| Drug | D 247 | 1.71e-04 | 5 | 95 | 2 | CID003048156 | |
| Drug | 6-quinolinecarbaldehyde | 1.71e-04 | 5 | 95 | 2 | CID000765653 | |
| Drug | chromotropic acid | 1.71e-04 | 5 | 95 | 2 | CID000067220 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; ssMCF7; HG-U133A | 1.74e-04 | 196 | 95 | 6 | 403_UP | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 1.74e-04 | 196 | 95 | 6 | 592_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 4655_DN | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2174_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2270_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 5757_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2551_DN | |
| Drug | AC1Q6O8T | 1.78e-04 | 197 | 95 | 6 | CID000002193 | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; HL60; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3045_UP | |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 7334_UP | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 1705_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 6758_DN | |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 4398_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6248_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3434_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A | 1.83e-04 | 198 | 95 | 6 | 664_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5680_UP | |
| Drug | fludrocortisone acetate; Down 200; 1uM; MCF7; HG-U133A | 1.83e-04 | 198 | 95 | 6 | 281_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6129_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 3249_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 4564_DN | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1702_DN | |
| Drug | DAPH1 | 1.91e-04 | 27 | 95 | 3 | CID000133027 | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 2481_UP | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 3385_DN | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 2272_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HG-U133A | 1.94e-04 | 200 | 95 | 6 | 418_UP | |
| Drug | 2,3-pentanedione | 2.08e-04 | 129 | 95 | 5 | ctd:C013186 | |
| Drug | Raloxifene Hydrochloride | ERBB3 TNC ENPP2 UPF1 ABLIM3 IGFBP3 HMCN1 JAG1 ARHGAP29 LTBP1 HAS2 NOTCH3 | 2.33e-04 | 857 | 95 | 12 | ctd:D020849 |
| Drug | monatepil | 2.38e-04 | 29 | 95 | 3 | CID000060810 | |
| Drug | AC1O5SNJ | 2.56e-04 | 6 | 95 | 2 | CID006439900 | |
| Drug | SnCe6 | 2.56e-04 | 6 | 95 | 2 | CID000164259 | |
| Drug | diethyl ester | 2.56e-04 | 6 | 95 | 2 | CID000264327 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.23e-08 | 3 | 95 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | TRPM6 SPRY2 ERBB3 ENPP2 FAT3 SEMA5A TINAGL1 NELL1 CELSR1 FBN1 FBN2 ADAMTS7 TLL1 JAG1 HAS3 TNXB FBN3 | 1.26e-06 | 1345 | 95 | 17 | EFO_0010736 |
| Disease | aortic measurement | 1.58e-06 | 251 | 95 | 8 | EFO_0020865 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.95e-06 | 28 | 95 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | ascending aortic diameter | 6.29e-06 | 140 | 95 | 6 | EFO_0021787 | |
| Disease | Squamous cell carcinoma of esophagus | 1.43e-05 | 95 | 95 | 5 | C0279626 | |
| Disease | Junctional epidermolysis bullosa | 3.07e-05 | 3 | 95 | 2 | cv:C0079301 | |
| Disease | Weill-Marchesani syndrome | 3.07e-05 | 3 | 95 | 2 | C0265313 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 3.07e-05 | 3 | 95 | 2 | cv:C0079683 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 3.07e-05 | 3 | 95 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 3.07e-05 | 3 | 95 | 2 | C1869114 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 3.07e-05 | 3 | 95 | 2 | 226700 | |
| Disease | cortical thickness | ERBB3 ENPP2 FAT3 NELL1 CELSR1 FBN1 FBN2 IGFBP3 MEGF9 ADAMTS7 JAG1 LRP1 HAS3 | 5.79e-05 | 1113 | 95 | 13 | EFO_0004840 |
| Disease | scoliosis (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 6.13e-05 | 4 | 95 | 2 | cv:C0265313 | |
| Disease | Herlitz Disease | 6.13e-05 | 4 | 95 | 2 | C0079683 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Epidermolysis Bullosa Progressiva | 6.13e-05 | 4 | 95 | 2 | C0079297 | |
| Disease | Skin Ulcer | 6.13e-05 | 4 | 95 | 2 | C0037299 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.90e-05 | 139 | 95 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 1.02e-04 | 5 | 95 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.02e-04 | 5 | 95 | 2 | C0265287 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.02e-04 | 5 | 95 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.02e-04 | 5 | 95 | 2 | C2608084 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 1.02e-04 | 5 | 95 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Glioblastoma | 1.26e-04 | 79 | 95 | 4 | C0017636 | |
| Disease | age of onset of asthma | 1.26e-04 | 79 | 95 | 4 | OBA_2001001 | |
| Disease | Junctional Epidermolysis Bullosa | 1.53e-04 | 6 | 95 | 2 | C0079301 | |
| Disease | Giant Cell Glioblastoma | 1.60e-04 | 84 | 95 | 4 | C0334588 | |
| Disease | Head and Neck Neoplasms | 1.64e-04 | 33 | 95 | 3 | C0018671 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 2.13e-04 | 7 | 95 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 2.13e-04 | 7 | 95 | 2 | C0399367 | |
| Disease | cholesteryl ester 16:2 measurement | 2.13e-04 | 7 | 95 | 2 | EFO_0021435 | |
| Disease | Mammary Carcinoma, Human | 2.99e-04 | 525 | 95 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.99e-04 | 525 | 95 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.06e-04 | 527 | 95 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 3.52e-04 | 538 | 95 | 8 | C0678222 | |
| Disease | Malignant Head and Neck Neoplasm | 3.89e-04 | 44 | 95 | 3 | C0278996 | |
| Disease | ovarian serous carcinoma | 4.44e-04 | 46 | 95 | 3 | EFO_1001516 | |
| Disease | Bone Diseases | 4.54e-04 | 10 | 95 | 2 | C0005940 | |
| Disease | aortic aneurysm | 4.54e-04 | 10 | 95 | 2 | EFO_0001666 | |
| Disease | tenascin measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0008296 | |
| Disease | Head and Neck Carcinoma | 4.54e-04 | 10 | 95 | 2 | C3887461 | |
| Disease | Glioblastoma Multiforme | 4.64e-04 | 111 | 95 | 4 | C1621958 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.35e-04 | 49 | 95 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Microphthalmos | 5.54e-04 | 11 | 95 | 2 | C0026010 | |
| Disease | Marfan Syndrome | 5.54e-04 | 11 | 95 | 2 | C0024796 | |
| Disease | FEV/FEC ratio | NID2 SPRY2 ERBB3 TUT1 FBN1 HMCN1 LRP1 SCUBE3 LTBP1 LTBP2 LTBP3 TNXB | 5.78e-04 | 1228 | 95 | 12 | EFO_0004713 |
| Disease | Mitral valve prolapse, response to surgery | 6.63e-04 | 12 | 95 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 6.63e-04 | 12 | 95 | 2 | EFO_0010822 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.74e-04 | 53 | 95 | 3 | C4707243 | |
| Disease | Malignant neoplasm of breast | NID2 ERBB3 DLL4 KMT2D EGF DKK1 IGFBP5 TLL1 JAG1 ARHGAP29 NOTCH3 | 6.76e-04 | 1074 | 95 | 11 | C0006142 |
| Disease | body weight | NID2 LRP1B CRB1 NELL1 EYS FBN2 MICALL2 TLL1 TEX29 LTBP1 LTBP2 LTBP3 | 7.29e-04 | 1261 | 95 | 12 | EFO_0004338 |
| Disease | IGFBP-1 measurement | 7.82e-04 | 13 | 95 | 2 | EFO_0005118 | |
| Disease | Migraine Disorders | 7.82e-04 | 13 | 95 | 2 | C0149931 | |
| Disease | gallbladder cancer (is_implicated_in) | 7.82e-04 | 13 | 95 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | optic cup area measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0006940 | |
| Disease | Liver Cirrhosis, Experimental | 8.84e-04 | 774 | 95 | 9 | C0023893 | |
| Disease | Chromosome Breakage | 9.10e-04 | 14 | 95 | 2 | C0376628 | |
| Disease | Hypodontia | 9.10e-04 | 14 | 95 | 2 | C0020608 | |
| Disease | Chromosome Breaks | 9.10e-04 | 14 | 95 | 2 | C0333704 | |
| Disease | Bladder Neoplasm | 1.11e-03 | 140 | 95 | 4 | C0005695 | |
| Disease | body surface area | 1.12e-03 | 643 | 95 | 8 | EFO_0022196 | |
| Disease | Malignant neoplasm of urinary bladder | 1.14e-03 | 141 | 95 | 4 | C0005684 | |
| Disease | Dermatitis | 1.20e-03 | 16 | 95 | 2 | C0011603 | |
| Disease | intraocular pressure measurement | 1.31e-03 | 509 | 95 | 7 | EFO_0004695 | |
| Disease | glaucoma | 1.57e-03 | 154 | 95 | 4 | MONDO_0005041 | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.69e-03 | 19 | 95 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.69e-03 | 19 | 95 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | ENPP2 FAT3 FBN1 FBN2 IGFBP3 JAG1 LRP1 LTBP1 LTBP2 LTBP3 HYDIN NOTCH3 | 1.70e-03 | 1392 | 95 | 12 | EFO_0005763 |
| Disease | migraine disorder, endometriosis | 1.71e-03 | 73 | 95 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.88e-03 | 20 | 95 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Osteoarthritis of hip | 1.88e-03 | 20 | 95 | 2 | C0029410 | |
| Disease | epilepsy (implicated_via_orthology) | 1.93e-03 | 163 | 95 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 2.03e-03 | 550 | 95 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | treatment resistant depression, response to antidepressant | 2.07e-03 | 21 | 95 | 2 | EFO_0009854, GO_0036276 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.22e-03 | 80 | 95 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.22e-03 | 80 | 95 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Hepatitis | 2.27e-03 | 22 | 95 | 2 | HP_0012115 | |
| Disease | Cleft Palate | 2.30e-03 | 81 | 95 | 3 | C0008925 | |
| Disease | arginine measurement | 2.48e-03 | 23 | 95 | 2 | EFO_0020990 | |
| Disease | information processing speed | 2.64e-03 | 85 | 95 | 3 | EFO_0004363 | |
| Disease | congenital heart disease (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | unipolar depression, neuroticism measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.70e-03 | 24 | 95 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 2.70e-03 | 24 | 95 | 2 | C0887833 | |
| Disease | descending aortic diameter | 2.91e-03 | 88 | 95 | 3 | EFO_0021788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QCLSCRNYSRGGVCV | 516 | P21860 | |
| IQCYRCGDTCKGEVV | 21 | O94929 | |
| GYENLCCLRCIQTRD | 96 | P41223 | |
| QCYLVENIGAFCRCN | 386 | O95196 | |
| RCYGGRCKTRDRQCQ | 541 | O75078 | |
| SCRERNQGANYACEC | 376 | Q9NR61 | |
| NFCDGRRCQNGGTCV | 1651 | Q9NYQ6 | |
| GVCENLRGSYRCVCN | 696 | Q75N90 | |
| FCLRVQDNGCLIACG | 456 | Q9GZS0 | |
| GCVIIDLCCQDNGRT | 366 | Q9BYV7 | |
| TCGRGVQRQNVYCLE | 836 | Q9UKP4 | |
| CQCRGLYTGQRCQLS | 4076 | Q14517 | |
| AVCQCDSGFRGERCQ | 4111 | Q14517 | |
| QLCLYRGNSRRTCAC | 2156 | Q9NZR2 | |
| NCNCSGLQRYERNIC | 626 | Q5T1H1 | |
| CGETCDRCCTGYNQR | 326 | Q16787 | |
| CQQLCLYRGRGQRAC | 2166 | Q07954 | |
| CDGRTNLCCRQQFFI | 296 | P09529 | |
| VCQRVVCQRYAGANG | 1406 | O75197 | |
| CRQQCEGYRDVNICN | 11 | Q8IY33 | |
| VAQLQGECLGYQCCV | 401 | Q86VH2 | |
| CENGRCVRVQEGYTC | 1631 | Q14766 | |
| GVIEDNCGRTCYCIA | 1616 | Q7Z5P9 | |
| FGVCRDGINRYDCVC | 631 | Q9UM47 | |
| CLIDQFRCANGQCIG | 1326 | O75581 | |
| RCNQTTGQCECRPGY | 216 | Q9H1U4 | |
| SCGVYTERCAQGLRC | 66 | P24593 | |
| CRGICNCSYCRKRDG | 406 | Q96GN5 | |
| NCSYCRKRDGRCATG | 411 | Q96GN5 | |
| AYSRCIQACGQERGQ | 751 | Q96FC9 | |
| NYGVRCVACCRVLPS | 201 | A6NMN3 | |
| NGTICRAFCEEGCRY | 511 | Q92832 | |
| NQICENTRGSYRCVC | 5286 | Q96RW7 | |
| PCGCIINCRQNAYAV | 371 | Q86SP6 | |
| YCQTKFCARCGGRVS | 141 | Q9UQ26 | |
| SVCINLPGSYRCECR | 816 | Q14112 | |
| FCCLECETVLGGQRY | 216 | Q96MT3 | |
| CCFECETVLGGQRYI | 221 | Q7Z3G6 | |
| CDTINCERYNGQVCG | 536 | P05107 | |
| ENRALCLQGIYRVCG | 696 | Q52LW3 | |
| LGETVLECYNCGCRN | 176 | Q92900 | |
| LECYNCGCRNVFLLG | 181 | Q92900 | |
| QYCQCRGRLNCIMGS | 351 | Q9UKF2 | |
| GTCCQYQLYCRGICT | 2776 | Q4G0P3 | |
| YRSCRQECPLQGNAC | 266 | Q9NZD1 | |
| CNCVVGYIGERCQYR | 1001 | P01133 | |
| DYCQLVRYLCQNGRC | 451 | P35555 | |
| GRCVNTDGSYRCECF | 626 | P35555 | |
| RCLNTRGSYTCECND | 2306 | P35555 | |
| RCQHGCQNIIGGYRC | 2576 | P35555 | |
| QYLGNIAERTCCCTF | 1376 | A8TX70 | |
| LAYSRCIQACGQERG | 751 | A8MPP1 | |
| CPRFYRNVRCTCNGG | 3776 | Q8TDW7 | |
| IERACQSYFGCVQCI | 266 | Q92819 | |
| CVAALCERPQGCQQY | 306 | P98153 | |
| NGCENGRCVRVREGY | 1741 | Q14767 | |
| GRCVRVREGYTCDCF | 1746 | Q14767 | |
| CRNGVCENTRGGYRC | 1046 | Q9NS15 | |
| IDLQGSCCEGYLCNR | 201 | Q6UWN5 | |
| CRRNAGVCAVNGLLY | 526 | Q9UH77 | |
| RIGSRAYSQGCCSCL | 36 | Q9ULL0 | |
| QCQRGYCNRYPVCVA | 566 | Q13751 | |
| CQLGSSLYRGCQQTC | 46 | Q8IUC0 | |
| CQLGSSLYRGCQEIC | 46 | Q52LG2 | |
| CQLGSSLYRGCQETC | 46 | Q3SY46 | |
| RACQSYFGCVQCISG | 271 | O00219 | |
| NGICENLRGSYRCNC | 781 | P35556 | |
| NGVCINQIGSFRCEC | 1821 | P35556 | |
| NGRCVNIIGSYRCEC | 2351 | P35556 | |
| LCVDGENRYSCNCTG | 276 | P82279 | |
| RQCRICGGLAMYECR | 786 | Q9NQC7 | |
| NCLIGGVSFTYCCTR | 81 | P12838 | |
| LEIFQRCYCGEGLSC | 231 | O94907 | |
| RCYCGEGLSCRIQKD | 236 | O94907 | |
| CSINRGGCRFGCINT | 361 | Q8IX30 | |
| CRSQVRCEGFVCAQT | 116 | P07358 | |
| RCEGFVCAQTGRCVN | 121 | P07358 | |
| ARGDCCTNYQVVCKG | 126 | Q13822 | |
| CYRKNGAVRCICNEN | 146 | Q16363 | |
| DASCRDLVNGYRCIC | 461 | P78504 | |
| CGIYTERCGSGLRCQ | 81 | P17936 | |
| RDAGGRYCQEQDLCC | 41 | Q9GZM7 | |
| CEQRCLNTLGSYQCA | 586 | O43897 | |
| LQAVCCSGCRGQRVG | 231 | A8MTI9 | |
| QRICGARVGCSNIAY | 356 | Q2M3M2 | |
| RYCGRNVIENCICAN | 171 | Q8NH54 | |
| CRCGYDCPNRVVQKG | 226 | O43463 | |
| FIEGGRRYQCGFCNC | 376 | O94855 | |
| RRYQCGFCNCVNDVP | 381 | O94855 | |
| GCYDRVNRPGCRCKN | 281 | O43597 | |
| GRVCVGQNREERYCN | 631 | Q13591 | |
| CYICKQRGSGACIQC | 386 | P55201 | |
| RVYKCQGGSCLSRAC | 196 | Q14CN2 | |
| CGIVYCRTREACEQL | 261 | O94762 | |
| NIECVECCGRDLYVG | 26 | Q8WUH2 | |
| ELYACQRGCRLFSIC | 66 | Q9BXS4 | |
| ICGRCQVARYCGSQC | 186 | Q96E35 | |
| LQCEICGYQCRQRAS | 556 | Q96CK0 | |
| CQNLIRCYCGRLIGD | 46 | Q9BX84 | |
| GRLQNCCRAAANYCR | 561 | Q9H6E5 | |
| VCYQCCGSLRAAARR | 61 | Q08AE8 | |
| GRCVQGVCVCRAGFS | 226 | P22105 | |
| NNCYNRGRCVENECV | 286 | P24821 | |
| GRCVNGQCVCDEGYT | 416 | P24821 | |
| LGQCVSGRCICNEGY | 601 | P24821 | |
| ECVNTFGSYLCRCRN | 746 | Q9Y6L7 | |
| SCTCQEGYRGDGQVC | 261 | Q8WWQ8 | |
| VCRQLGCRGAQQAYD | 471 | Q4G0T1 | |
| YNVSRDRCQELGCCF | 31 | Q8N6K0 | |
| CPQAARCCRTGVDEY | 56 | A2RRL7 | |
| CARYQRGECQACDQL | 91 | Q96H79 | |
| TNNRRCCYRCSIGEN | 5221 | O14686 |